rfhg_209842.1

Basic information about the TSS

---

TSS ID: rfhg_209842.1 Species: human Chr: chr19		Start: 19405699 End: 19405730 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D3049269,EH38E1945202)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000683918.1:-24 GeneID: 54815 HGNC/MGI_ID: HGNC:29989 UniProt_ID: A0A024R7M6 Nearer transcript ids and distances: ENST00000448576.6:108

Gene_name: GATA zinc finger domain containing 2A Gene_symbol: GATAD2A Gene_synonyms: p66alpha Gene_source: HGNC:29989

TATA-Box annotation

---

Distance to TSS:	19911
Nearest PromoterID:	NM_001359631
Entrez ID:	54815
Nearest Unigene:	Hs.118964
Nearest Refseq:	NM_017660
Nearest Ensembl:	ENSG00000167491
Gene Name:	GATA zinc finger domain containing 2A
Gene Alias:	p66alpha
Gene Type:	protein-coding
CpG%:	0.161290
GC%:	0.718750
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	11(GCCTTTAAGAGC,-,0.00),12(CCTTTAAGAGCT,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GATAD2A p2@GATAD2A p3@GATAD2A p4@GATAD2A p5@GATAD2A p6@GATAD2A p7@GATAD2A p8@GATAD2A
Sample		p1@GATAD2A	p2@GATAD2A	p3@GATAD2A	p4@GATAD2A	p5@GATAD2A	p6@GATAD2A	p7@GATAD2A	p8@GATAD2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	24.55	16.17	11.49	2.53	1.95	6.04	4.09	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.86	18.41	10.72	3.03	0.81	5.46	3.84	3.64
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.59	14.47	11.38	3.86	1.54	5.79	3.09	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.40	12.27	13.51	1.66	0.83	3.74	2.91	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.55	15.07	12.60	3.15	1.57	5.85	3.82	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.93	14.34	12.02	1.55	0.97	6.78	2.91	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.61	22.22	15.25	1.74	2.40	2.61	3.70	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.10	16.96	9.69	0.97	1.21	4.60	3.39	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	21.16	10.26	2.99	2.35	5.77	2.14	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.81	19.13	20.87	0.58	1.74	2.32	2.90	9.85
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.30	20.62	19.81	0.40	4.04	2.02	2.02	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	17.08	21.14	1.63	2.03	2.03	3.25	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.73	5.96	1.13	3.71	2.10	2.26	1.13	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.34	4.81	1.65	1.95	1.20	0.90	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.76	6.15	1.76	2.85	1.32	1.10	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.60	5.03	1.51	3.02	0.75	0.75	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.20	4.59	1.97	2.18	0.87	0.44	1.09	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	4.64	2.11	1.69	2.11	1.27	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	9.60	1.07	1.07	1.07	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.90	5.27	1.50	1.81	0.75	1.50	1.50	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	17.11	5.88	1.47	3.34	1.20	1.87	0.94	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	18.47	5.70	2.76	2.76	1.21	1.73	1.38	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.61	4.65	1.55	2.07	0.52	1.55	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.71	5.82	0.97	1.94	0.73	1.70	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.32	7.22	2.58	1.03	2.06	1.55	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.62	6.01	1.58	2.53	0.32	2.53	2.85	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	5.49	1.65	1.10	1.10	0.55	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.34	7.07	0.71	2.12	0.47	1.89	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.06	5.33	2.91	2.10	0.81	2.10	1.94	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	7.24	2.71	2.71	0.18	2.90	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.93	4.61	1.26	1.47	1.05	1.47	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.52	6.25	1.76	1.95	0.59	1.37	1.95	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.52	6.54	1.27	1.69	1.27	1.90	1.06	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.33	4.62	1.65	2.64	1.32	2.14	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.89	10.10	2.24	2.99	0.75	1.31	1.50	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.57	6.52	3.64	2.68	2.11	1.15	1.34	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.99	5.11	2.86	3.68	0.61	1.43	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.34	5.24	1.61	2.42	1.21	1.61	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.10	5.13	2.43	1.08	0.81	1.62	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	22.81	7.68	2.88	1.44	0.96	1.44	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.47	6.82	2.12	2.59	0.71	1.41	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.37	5.27	2.05	1.02	0.29	1.90	0.88	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.57	11.81	2.74	3.59	1.69	0.84	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.80	7.17	1.75	3.67	1.40	1.57	1.75	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.70	9.03	3.61	2.41	1.20	1.20	1.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.08	7.91	3.49	3.02	0.93	3.02	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.39	8.88	3.12	2.16	0.96	1.92	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.58	8.05	1.19	1.79	0.60	1.79	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.54	10.29	1.68	2.15	2.39	2.15	1.91	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.37	6.07	2.63	2.02	1.42	1.42	1.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.71	5.33	1.43	1.43	1.64	1.02	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.01	8.01	4.89	2.22	0.89	0.89	1.56	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	6.74	3.55	1.42	0.71	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.27	12.59	1.99	1.33	1.66	1.33	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	3.36	0.84	1.68	1.68	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	2.76	0.92	0.46	0.46	0.00	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.29	7.78	3.57	2.92	1.30	1.30	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.85	7.07	2.57	2.57	0.64	1.28	1.61	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.20	5.03	1.26	1.26	2.20	0.63	2.20	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	9.17	2.12	2.82	2.12	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.97	5.61	2.80	0.56	2.80	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	4.78	4.78	0.80	0.80	0.80	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.85	4.08	1.70	1.70	1.36	0.68	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.67	8.77	1.62	0.65	1.30	0.97	1.30	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	10.65	6.39	2.84	1.06	0.71	1.42	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	32.33	0.00	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	15.79	7.90	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.75	10.73	1.95	0.49	2.93	1.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.88	11.90	0.99	1.49	0.50	0.50	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	7.04	1.41	0.94	0.00	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.62	2.65	2.98	0.33	1.66	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.73	7.11	1.24	1.86	0.31	0.31	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.62	6.11	1.53	2.14	0.31	0.31	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	8.39	2.69	0.79	3.96	0.48	0.95	0.79	0.32
Adipocyte - breast, donor2	11327-117E4	15.24	4.97	0.96	2.89	1.12	0.48	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	10.43	5.09	0.76	2.80	0.51	0.76	2.42	0.25
Adipocyte - omental, donor2	11474-119C7	10.46	4.48	0.75	2.24	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	9.38	4.02	0.67	1.34	0.67	0.33	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.93	3.19	0.00	1.91	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	1.10	0.00	2.20	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	17.61	5.87	1.35	2.71	0.00	1.35	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	10.77	2.26	0.70	3.13	0.17	0.87	1.22	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.64	7.04	3.13	6.26	3.32	4.30	2.15	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	7.46	3.09	1.29	2.83	1.29	0.77	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	15.33	7.25	2.23	1.67	1.39	1.95	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	15.87	10.58	2.94	4.11	0.59	1.18	0.59	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	21.31	7.32	1.93	5.63	1.37	1.77	2.25	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	18.72	13.56	3.23	4.20	1.61	1.61	1.61	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	5.87	1.07	3.20	1.07	1.60	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	6.68	2.23	0.56	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	10.81	5.41	1.25	3.74	0.00	1.66	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.32	7.28	3.01	3.27	1.26	0.50	1.51	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.78	4.58	0.65	1.31	1.96	1.31	2.62	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	12.18	8.22	1.52	2.13	0.91	1.83	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	32.04	16.13	4.42	7.07	3.31	3.54	4.64	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	32.63	19.00	6.81	8.25	3.94	3.23	2.87	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	8.39	1.20	5.99	1.20	3.59	2.40	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	19.07	9.89	6.84	9.71	4.14	3.42	5.94	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	13.39	3.35	15.06	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	20.34	11.30	3.49	11.92	2.88	3.90	3.49	0.00
Anulus Pulposus Cell, donor1	11248-116E6	7.78	4.58	0.46	2.06	0.69	1.03	1.03	0.11
Anulus Pulposus Cell, donor2	11463-119B5	9.55	2.94	0.24	1.96	0.73	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	2.70	1.35	1.35	3.15	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	3.47	0.87	1.30	0.87	1.74	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.86	4.78	1.20	2.09	1.79	0.60	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	1.26	0.00	1.26	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	1.32	1.32	0.00	0.66	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.45	2.92	0.00	1.30	0.97	0.97	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	5.83	0.97	1.94	0.97	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	4.75	1.19	1.78	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.17	1.13	1.88	4.14	0.00	1.88	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	2.18	1.45	0.73	2.18	3.63	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	5.02	1.25	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.24	2.97	0.49	2.64	0.82	0.49	0.49	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	6.82	1.36	4.09	0.00	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.29	2.56	1.21	0.90	0.75	0.75	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	3.21	1.07	3.75	0.54	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.09	4.16	1.32	3.21	0.76	0.38	1.51	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.68	5.88	0.53	3.21	0.80	1.34	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	2.93	0.98	1.95	2.93	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.45	3.48	0.33	2.65	0.17	1.00	0.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	6.00	0.00	2.40	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	10.62	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.04	6.35	0.86	2.74	0.51	1.03	1.20	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	4.37	0.00	0.97	0.00	0.00	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.00	3.42	0.76	2.66	1.52	0.76	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	2.42	0.00	2.42	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	6.27	0.57	3.99	1.14	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.69	5.34	0.64	3.63	0.86	0.86	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.90	4.65	0.77	2.32	0.52	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	4.22	0.47	4.22	0.94	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.36	3.54	0.96	2.57	0.32	0.64	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	4.28	0.71	2.85	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	1.75	0.58	1.17	1.17	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.44	4.22	0.00	3.61	0.30	0.30	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	7.13	1.19	1.19	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	2.54	0.00	3.05	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.46	3.82	0.76	2.04	0.76	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	1.27	0.64	0.64	0.64	1.91	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	2.59	0.43	3.02	1.29	0.86	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.22	6.99	1.69	2.96	0.64	0.42	1.69	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.86	5.51	0.00	1.45	0.29	0.29	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	4.72	0.00	3.78	1.89	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.12	3.56	1.02	2.03	0.85	0.85	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	4.23	0.00	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.22	4.07	1.07	1.72	0.64	1.50	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	3.61	1.20	0.60	1.20	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	4.37	0.73	0.73	1.46	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.80	3.45	0.46	2.53	0.69	1.38	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	2.55	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.83	3.56	0.25	1.53	0.51	1.02	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.26	5.16	1.24	3.30	0.83	1.45	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	5.81	1.53	3.06	0.61	0.31	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	2.87	0.00	0.48	0.00	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.65	3.99	0.44	3.99	0.22	0.67	1.11	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	6.10	1.53	1.53	1.53	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	2.77	0.55	0.55	0.55	0.55	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	4.77	0.26	1.85	0.79	1.06	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.72	3.63	0.73	1.82	0.73	1.45	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	31.69	8.47	3.07	12.40	2.95	2.33	2.33	0.61
Astrocyte - cerebellum, donor2	11580-120F5	33.89	11.81	2.91	10.95	1.54	2.23	2.23	0.51
Astrocyte - cerebellum, donor3	11661-122F5	18.67	6.92	2.94	7.55	2.31	1.26	1.68	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	17.78	8.02	2.44	5.93	0.70	2.09	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	26.37	11.65	4.37	6.79	2.43	2.75	2.59	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	11.93	2.68	8.05	1.04	1.94	3.88	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	51.04	22.36	6.54	3.44	7.11	4.13	2.87	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	61.26	27.56	8.77	2.13	5.89	4.13	3.13	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	53.26	24.47	6.60	3.30	5.12	3.64	3.30	0.68
Basophils, donor1	12241-129G9	20.14	19.61	26.15	4.18	20.40	2.88	1.83	8.63
Basophils, donor2	12242-129H1	42.57	25.98	24.53	4.33	19.48	1.44	3.25	8.30
Basophils, donor3	12243-129H2	23.37	21.61	24.25	5.44	12.49	3.53	4.56	6.47
Bronchial Epithelial Cell, donor1	11511-119G8	12.29	10.35	3.88	10.35	3.02	1.51	3.67	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	17.37	10.97	3.66	8.23	2.74	2.29	2.74	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	15.06	5.02	1.26	0.63	3.14	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	27.66	24.75	4.99	4.78	3.33	1.66	1.25	2.08
Bronchial Epithelial Cell, donor6	11461-119B3	24.64	16.58	5.30	6.22	4.38	2.07	2.99	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	10.26	7.38	1.98	4.68	2.52	0.36	0.72	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	46.27	19.79	6.39	2.06	2.68	4.33	1.96	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	49.84	21.89	3.03	5.59	2.10	6.06	5.59	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.62	11.83	3.52	2.56	5.76	2.56	2.56	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00	10.34	0.00	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	26.49	25.36	46.78	4.51	19.16	2.82	3.38	13.53
CD14+ Monocytes, donor2	11305-117B9	25.43	33.96	46.21	2.60	22.46	1.30	1.67	16.33
CD14+ Monocytes, donor3	11381-118B4	21.08	36.00	40.39	4.61	23.71	0.88	2.41	11.42
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	13.59	14.15	8.21	2.83	6.51	1.98	0.57	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.03	17.06	9.48	3.03	6.44	2.27	1.14	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	14.14	17.75	10.52	5.26	9.53	2.30	1.97	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	11.71	27.61	31.95	7.08	15.18	4.05	4.77	17.06
CD14+ monocytes - mock treated, donor2	11873-125C1	18.41	30.48	37.72	5.43	15.39	6.03	6.94	25.95
CD14+ monocytes - mock treated, donor3	11883-125D2	14.21	28.66	40.03	5.69	18.95	7.11	3.08	25.11
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.69	23.77	30.13	2.51	11.05	2.01	2.34	16.91
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.38	28.71	36.71	2.76	11.32	9.66	2.21	27.33
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.18	29.75	34.46	2.23	15.37	8.18	1.98	28.76
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.72	24.67	16.25	2.94	7.05	1.37	0.78	9.01
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.55	24.04	23.15	3.20	9.97	2.49	2.31	20.83
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.35	17.85	29.60	2.18	13.93	2.39	1.96	21.76
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.98	23.18	20.13	3.04	9.37	1.17	1.17	12.41
CD14+ monocytes - treated with Candida, donor2	11878-125C6	24.29	31.68	39.60	4.22	16.90	6.86	2.64	27.99
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	19.97	18.86	2.22	9.98	5.55	0.00	24.41
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.33	21.57	28.71	5.80	13.68	2.97	3.72	18.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.37	25.14	35.12	4.39	12.17	7.38	3.79	26.74
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.04	14.57	22.28	3.54	8.33	5.83	0.62	16.03
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.41	24.94	30.66	2.29	10.75	2.29	1.83	19.90
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10.63	27.37	42.98	3.39	10.18	5.43	1.81	27.82
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.22	24.01	40.59	4.36	11.78	2.18	1.75	23.57
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3.50	23.67	19.64	4.84	12.10	0.81	0.54	8.07
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	9.94	28.26	29.13	4.01	15.00	4.36	1.92	20.76
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.10	30.30	29.04	4.21	12.62	0.84	2.10	23.99
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	25.72	27.37	1.29	7.53	1.29	0.92	14.15
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.99	33.11	40.16	1.76	10.92	5.99	2.11	31.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.70	37.29	37.73	1.75	9.65	2.63	0.88	29.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.28	25.11	21.97	4.71	12.55	3.31	2.27	14.82
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	19.33	31.96	2.23	16.73	8.18	4.83	32.34
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.68	19.83	29.53	2.37	12.29	8.41	1.51	19.61
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.32	18.02	18.43	2.05	5.32	1.23	1.23	6.55
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.56	22.02	39.41	1.16	8.81	4.17	1.62	20.40
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.78	21.58	29.93	1.86	9.28	3.25	0.00	13.69
CD14+CD16+ Monocytes, donor1	11789-124B7	5.67	7.85	8.94	1.53	4.14	0.87	1.31	1.74
CD14+CD16+ Monocytes, donor2	11801-124D1	6.93	11.55	10.39	3.23	5.77	0.23	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	4.12	9.10	6.72	2.82	5.20	1.08	1.52	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	9.34	20.71	17.60	3.89	12.92	1.56	2.02	2.80
CD14+CD16- Monocytes, donor2	11799-124C8	7.68	13.97	11.70	2.79	9.78	0.52	1.40	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	10.70	23.41	20.96	5.13	16.05	0.89	2.68	3.34
CD14-CD16+ Monocytes, donor1	11790-124B8	3.57	10.46	16.84	2.30	6.89	1.79	0.77	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	4.39	10.98	12.52	3.73	3.73	0.88	2.20	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	7.16	9.90	9.90	4.42	5.90	0.21	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	6.10	14.23	2.03	6.10	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	10.17	6.78	0.68	2.71	1.36	1.36	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	5.18	1.04	1.04	6.21	2.07	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	20.79	6.40	7.46	1.07	3.73	2.67	2.67	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	19.30	5.90	7.50	1.07	5.36	3.22	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	24.57	7.72	4.91	2.81	3.51	1.40	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	22.75	2.35	4.71	3.14	3.14	3.14	2.35	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	5.27	5.27	2.64	3.95	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	41.10	15.62	18.08	3.29	8.22	2.47	6.58	0.82
CD19+ B Cells, donor2	11624-122B4	37.00	17.41	13.06	1.45	7.98	2.18	2.90	1.45
CD19+ B Cells, donor3	11705-123B4	43.92	15.65	10.60	1.01	6.06	2.02	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	27.07	17.37	6.87	1.21	9.70	9.29	2.83	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.97	18.38	7.59	1.20	7.19	6.79	2.80	1.20
CD34+ Progenitors, donor1	11545-120B6	19.08	8.03	10.04	1.00	9.04	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	27.53	14.61	17.42	3.37	12.36	1.12	1.69	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	17.66	12.40	4.88	3.38	4.13	1.50	2.63	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	27.73	8.12	5.64	2.48	7.89	1.58	1.80	1.35
CD4+ T Cells, donor1	11225-116C1	61.77	27.14	19.28	13.93	19.28	6.07	13.21	3.93
CD4+ T Cells, donor2	11306-117C1	56.95	17.76	17.15	20.21	15.31	4.29	9.80	1.22
CD4+ T Cells, donor3	11382-118B5	46.97	22.57	12.81	12.20	13.42	4.57	9.15	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	32.93	13.27	14.29	2.55	11.74	1.79	3.32	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	36.61	20.66	13.03	4.04	17.29	2.70	5.39	2.92
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	28.17	18.40	12.65	7.47	17.25	2.30	4.60	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	35.56	17.07	7.59	6.16	10.43	3.32	6.16	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	39.33	11.94	4.92	5.62	11.94	2.11	4.92	4.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	9.89	9.89	3.30	6.59	6.59	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.04	14.60	8.53	2.46	6.21	1.30	3.32	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.39	32.54	13.05	5.59	10.17	2.03	5.25	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.12	26.92	12.74	6.61	11.45	2.42	3.06	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	15.69	10.76	6.72	1.79	8.52	0.90	3.14	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	21.66	4.89	4.89	4.54	8.73	2.10	5.94	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	16.72	7.92	9.68	5.72	17.16	0.00	3.96	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.08	22.77	8.43	3.37	9.28	1.26	2.95	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	22.23	31.79	15.79	5.40	9.77	2.70	5.40	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.70	23.05	10.36	4.68	8.35	0.33	2.34	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	33.45	14.41	7.61	10.61	9.25	4.89	7.89	4.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	38.59	10.72	6.97	14.47	10.72	2.68	9.65	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	19.73	5.38	10.76	7.17	1.79	14.35	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.22	26.15	11.50	5.38	11.87	2.04	4.64	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	23.39	21.45	8.88	3.90	9.31	1.52	2.17	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	21.23	23.75	13.03	7.78	10.93	0.63	3.99	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	28.31	14.66	5.56	4.55	13.15	2.53	3.03	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.10	6.50	6.50	5.63	4.33	1.30	5.63	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.94	14.38	10.90	6.97	14.82	5.23	6.10	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	46.52	8.91	7.92	6.43	13.36	5.44	5.94	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	42.47	12.00	2.77	3.69	5.54	3.69	3.69	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	15.35	6.98	0.00	2.79	5.58	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	46.52	14.68	10.52	4.15	14.12	2.77	6.09	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	56.69	14.23	6.63	7.85	11.04	2.94	5.15	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	36.96	10.78	6.16	3.08	9.24	3.08	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	45.48	16.12	8.24	5.01	8.95	3.94	4.66	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	6.92	9.69	4.15	9.69	6.92	1.38	5.54
CD8+ T Cells, donor1	11226-116C2	71.70	36.34	19.32	5.24	7.53	4.26	6.55	2.95
CD8+ T Cells, donor2	11307-117C2	66.45	33.79	17.65	4.51	14.64	4.13	4.13	3.75
CD8+ T Cells, donor3	11383-118B6	87.61	30.55	15.40	7.32	13.38	6.06	10.35	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.93	16.97	2.98	0.92	1.38	1.61	1.38	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.18	15.34	5.75	1.20	1.20	2.16	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.04	15.32	1.92	1.37	0.82	1.64	0.82	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.81	11.71	3.30	0.90	2.70	1.50	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.56	13.44	3.12	0.72	1.20	1.68	0.72	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.01	16.60	3.18	0.68	0.68	1.59	1.36	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.56	11.08	2.82	0.87	0.87	1.09	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.58	16.32	2.90	1.05	1.05	1.84	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.43	15.48	3.75	0.94	0.94	0.70	1.17	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.40	16.91	3.62	1.51	0.60	0.91	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.94	13.36	2.91	0.58	0.87	2.32	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.99	15.19	2.66	0.53	1.07	0.53	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.13	25.39	3.06	0.44	2.63	3.94	0.44	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.30	23.23	5.47	1.37	1.37	5.92	0.46	4.10
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	26.11	5.97	1.49	0.75	5.97	0.00	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.16	17.65	3.60	1.80	0.36	1.44	1.08	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.98	9.49	3.74	1.15	1.15	0.86	1.15	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.73	11.55	3.30	0.71	1.18	3.06	1.18	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	15.21	1.58	2.85	1.58	1.58	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.99	13.53	4.00	0.31	0.92	0.92	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.94	9.62	2.89	1.28	0.96	1.60	0.96	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.24	13.39	2.68	0.38	0.00	3.06	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	12.22	2.76	1.18	0.39	3.15	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	7.56	1.51	1.51	0.76	2.27	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	36.94	12.85	0.00	3.21	8.83	0.00	5.62
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.99	28.68	12.59	0.70	4.90	9.09	0.00	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	24.04	11.02	1.00	5.01	9.02	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	23.76	9.14	5.48	1.83	0.00	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	6.92	7.41	1.48	3.46	1.48	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	9.37	4.31	1.89	3.37	1.26	1.26	1.68	0.42
Chondrocyte - de diff, donor1	11261-116G1	10.75	6.93	2.77	2.08	0.35	2.43	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	15.99	5.33	1.78	4.62	0.36	3.55	1.42	1.07
Chondrocyte - de diff, donor3	11410-118E6	12.74	4.44	0.91	2.05	1.37	1.02	1.59	0.11
Chondrocyte - re diff, donor2	11339-117F7	42.08	6.27	0.90	1.79	2.69	4.48	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	9.71	12.54	2.02	2.02	2.02	2.02	2.02	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	14.12	7.80	1.61	5.05	2.41	1.03	2.07	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	14.11	7.05	1.07	4.28	3.42	2.99	2.35	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	17.79	7.79	2.21	6.46	1.24	1.68	3.10	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.97	24.03	10.18	11.37	4.13	3.21	3.39	1.28
Corneal Epithelial Cells, donor1	11526-119I5	29.64	10.54	4.17	6.37	2.85	2.42	1.98	1.54
Corneal Epithelial Cells, donor2	11606-120I4	10.24	9.10	4.55	3.41	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.10	11.25	4.35	5.37	3.32	0.77	3.07	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	18.66	14.69	3.96	2.48	4.62	3.96	0.99	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	18.61	11.99	3.47	3.78	3.47	0.63	0.32	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	13.80	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.17	12.74	5.62	1.84	2.92	3.67	0.54	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	22.21	14.35	11.27	2.39	10.25	2.39	2.05	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	25.46	10.45	3.26	4.57	7.18	4.57	3.92	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	25.17	11.13	9.68	3.87	10.65	0.97	3.39	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	44.53	21.85	6.84	6.67	3.17	7.34	6.17	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	17.60	4.69	3.52	4.11	6.45	2.35	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	33.94	25.17	5.09	4.81	3.68	4.24	6.79	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	31.85	18.09	4.72	4.72	2.36	5.11	4.72	0.79
Endothelial Cells - Artery, donor1	11264-116G4	22.11	12.51	4.07	5.82	2.91	1.75	2.62	0.58
Endothelial Cells - Artery, donor2	11341-117F9	29.17	16.47	4.00	3.53	2.12	1.88	4.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	39.44	17.00	6.31	5.96	2.98	5.43	5.26	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.07	9.09	4.88	5.10	1.99	1.77	3.55	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	19.47	11.87	3.65	3.96	1.83	2.13	3.65	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.73	9.30	3.95	5.36	2.26	1.97	5.07	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	16.34	11.89	2.97	2.67	2.67	1.19	2.67	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	26.03	10.93	4.69	2.08	2.08	3.64	5.21	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	11.48	12.48	3.83	4.25	1.70	2.55	2.84	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	26.01	10.80	4.40	4.00	2.40	4.40	5.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	16.77	8.39	2.62	2.62	2.10	0.00	3.14	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.44	18.26	7.58	7.33	3.11	3.60	5.22	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.55	18.90	7.39	8.47	3.91	4.56	4.78	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	33.10	20.64	8.43	10.75	4.89	5.74	6.11	0.85
Endothelial Cells - Vein, donor1	11267-116G7	17.06	18.20	2.28	6.83	6.83	3.41	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	27.94	13.27	5.59	11.87	4.89	2.10	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	32.50	13.66	4.08	8.48	1.73	4.40	6.44	0.31
Eosinophils, donor1	12244-129H3	15.25	0.00	30.49	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	31.35	57.76	130.37	49.51	77.56	13.20	8.25	18.15
Eosinophils, donor3	12246-129H5	21.40	53.50	78.47	39.24	57.07	0.00	7.13	21.40
Esophageal Epithelial Cells, donor1	11507-119G4	15.39	12.70	6.35	8.06	1.71	2.69	2.20	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	20.80	2.08	2.08	6.24	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.78	9.85	1.23	5.34	0.41	2.05	2.87	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	3.18	0.44	1.97	0.22	0.33	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.94	4.66	1.73	2.49	0.54	0.65	1.73	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.95	6.79	1.94	6.67	1.21	2.30	2.30	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.28	5.60	1.91	1.23	1.64	1.09	1.23	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.87	6.96	1.16	4.32	0.42	1.16	1.27	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.22	3.95	1.84	1.58	2.63	1.58	1.58	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.91	13.62	2.33	6.98	2.99	2.33	3.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	13.16	9.07	1.81	0.91	0.45	1.81	3.18	0.45
Fibroblast - Cardiac, donor2	11345-117G4	18.95	12.89	3.79	6.06	4.55	4.55	5.31	0.76
Fibroblast - Cardiac, donor3	11417-118F4	14.98	7.41	2.05	5.20	1.10	1.89	1.58	0.63
Fibroblast - Cardiac, donor4	11452-119A3	20.91	12.43	1.82	2.73	1.82	1.82	2.12	0.00
Fibroblast - Cardiac, donor5	11456-119A7	20.56	10.79	1.27	5.20	1.02	2.03	4.31	0.51
Fibroblast - Cardiac, donor6	11460-119B2	20.16	13.64	3.03	5.46	1.52	2.73	3.49	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.17	6.70	1.47	3.89	2.14	0.54	2.01	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.53	12.94	2.16	1.29	0.43	0.43	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	5.86	4.39	4.39	0.00	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	76.11	15.91	3.23	11.76	2.08	5.77	5.30	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	11.53	4.07	0.85	4.75	0.51	1.36	2.37	0.51
Fibroblast - Dermal, donor1	11269-116G9	21.13	6.10	1.17	3.05	0.23	1.88	1.41	0.23
Fibroblast - Dermal, donor2	11346-117G5	34.90	10.85	4.25	5.66	1.89	6.60	3.30	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.24	6.04	0.48	2.42	0.24	2.42	1.21	0.12
Fibroblast - Dermal, donor4	11450-119A1	34.14	8.25	2.15	5.88	1.81	3.05	1.58	0.57
Fibroblast - Dermal, donor5	11454-119A5	37.51	13.96	2.44	6.11	1.57	1.92	2.97	1.05
Fibroblast - Dermal, donor6	11458-119A9	34.11	13.16	2.60	6.50	4.22	2.44	4.71	0.49
Fibroblast - Gingival, donor1	11237-116D4	22.49	10.00	2.29	2.71	1.25	2.50	2.50	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.30	9.43	2.62	1.57	2.62	2.36	2.88	0.26
Fibroblast - Gingival, donor2	11318-117D4	22.14	8.57	1.71	3.16	2.11	1.45	1.98	0.53
Fibroblast - Gingival, donor3	11394-118C8	29.30	9.86	1.93	3.67	2.22	1.74	1.55	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	19.74	3.12	1.04	2.08	1.04	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.22	4.23	1.23	1.41	1.41	0.88	1.23	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.05	11.54	3.43	3.43	2.49	1.87	2.18	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.83	11.36	2.16	2.16	2.03	2.16	1.08	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	30.70	16.59	6.35	3.53	6.00	3.18	2.82	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.21	12.43	1.61	3.22	1.46	2.34	1.17	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.82	9.82	1.09	3.27	1.50	2.05	1.23	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	31.70	18.32	4.50	3.73	3.29	3.62	2.85	1.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.33	3.52	1.32	1.61	2.35	0.44	1.32	0.59
Fibroblast - Lung, donor1	11270-116H1	24.47	6.80	1.36	0.00	2.72	1.36	6.80	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	7.46	2.98	2.98	0.00	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	24.06	7.60	1.27	5.06	1.90	3.80	3.38	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	66.64	15.83	6.66	13.33	5.00	4.17	12.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	6.99	1.40	18.18	1.40	0.00	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	19.03	9.24	2.24	5.88	1.12	1.40	1.96	0.00
Fibroblast - Mammary, donor1	11540-120B1	59.27	24.36	2.84	18.67	4.06	6.09	8.93	0.41
Fibroblast - Mammary, donor2	11620-122A9	55.92	3.99	3.99	7.99	3.99	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	5.96	0.00	0.00	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.28	8.34	1.36	3.30	2.13	1.55	2.91	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.74	13.80	1.52	6.37	4.40	3.64	3.94	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.64	12.24	3.06	2.45	2.14	3.67	2.45	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.65	5.72	1.91	3.05	0.38	1.91	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.28	8.91	1.62	2.16	2.16	1.35	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.08	8.70	1.04	3.36	0.93	1.51	1.74	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.82	9.17	2.54	3.98	0.33	1.44	2.54	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	38.20	20.52	4.67	7.72	3.66	4.67	2.64	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.08	15.37	4.01	6.01	2.00	4.01	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.12	4.74	1.58	1.58	1.19	1.98	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	11.91	7.34	5.16	1.19	4.56	1.39	1.79	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	4.26	0.89	2.66	0.53	0.53	0.18	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.98	5.72	1.58	2.96	1.18	1.97	1.58	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.43	8.72	5.42	0.90	2.71	0.90	1.81	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.08	6.80	1.51	4.10	1.08	1.30	2.05	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.64	4.56	1.77	0.76	2.53	0.76	0.51	2.28
Fibroblast - skin normal, donor1	11553-120C5	15.26	4.43	1.15	4.76	0.98	1.48	1.48	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.64	10.63	4.21	2.01	2.61	2.21	1.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	19.39	3.62	0.40	5.02	1.41	1.21	2.51	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	16.32	7.86	2.72	2.72	3.63	1.81	2.72	3.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.58	6.21	1.08	2.82	1.41	1.82	0.99	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.29	2.91	0.51	2.91	1.37	0.68	1.20	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4.60	7.55	2.96	1.64	3.28	0.99	1.64	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.56	5.54	1.81	6.71	1.60	1.92	2.45	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	18.55	6.07	1.52	3.20	1.52	2.02	2.36	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.63	3.29	0.63	2.51	0.47	0.63	1.41	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	22.66	30.50	6.97	6.10	2.61	4.36	8.72	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.35	9.36	2.77	3.64	2.60	1.73	1.56	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.53	15.09	5.47	1.56	1.82	2.60	0.52	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	22.74	14.31	6.90	2.30	3.58	1.28	2.04	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	37.51	18.37	3.06	4.59	2.30	8.42	6.89	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.03	14.68	3.19	3.83	1.91	8.29	4.47	5.74
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.35	18.83	8.84	10.27	7.70	10.55	9.13	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	38.88	12.13	5.24	5.52	6.89	3.03	3.31	4.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.91	15.53	8.45	3.20	7.76	3.88	3.42	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.16	15.45	7.53	6.93	7.53	11.49	8.32	3.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	31.98	9.52	5.55	1.59	7.14	3.44	1.59	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.68	23.48	6.52	3.91	5.87	4.89	2.94	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.09	7.52	4.86	3.10	5.31	5.75	5.31	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.46	13.71	3.67	5.37	3.11	3.67	4.24	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.22	14.53	3.45	7.14	3.94	4.19	4.56	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.73	10.75	5.10	4.03	3.22	3.49	4.30	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.54	16.35	6.57	9.91	4.46	4.83	4.46	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.82	18.96	5.12	6.64	3.60	6.09	5.12	3.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	28.87	16.26	7.52	4.68	3.05	6.51	3.46	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	20.08	13.01	8.21	7.07	3.19	4.56	2.05	2.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	25.16	14.45	6.60	9.22	3.86	2.62	4.98	3.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	31.48	17.49	8.31	8.52	3.50	7.21	4.15	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	19.21	12.11	4.43	6.50	2.07	2.95	3.84	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.34	12.72	3.18	8.11	3.50	2.86	4.77	3.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	12.29	8.94	6.93	6.03	3.80	3.13	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.95	11.90	4.23	10.28	2.82	1.81	3.83	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	22.90	20.02	5.94	7.12	2.88	1.53	3.39	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	30.06	20.66	9.75	10.02	3.37	4.88	4.79	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.34	20.92	7.39	11.97	3.95	3.02	4.99	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.13	18.44	7.00	7.00	3.76	2.73	4.61	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.89	18.15	5.53	10.40	2.10	2.10	3.87	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.22	15.97	6.07	5.57	2.83	2.50	3.16	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.19	12.25	7.55	6.33	3.68	2.86	2.65	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.15	13.41	3.71	6.81	3.30	0.83	3.30	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.29	17.29	3.57	6.92	2.31	2.88	3.00	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.01	14.18	5.67	6.00	3.00	2.84	3.67	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	15.87	11.46	5.95	9.48	2.42	1.54	3.75	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.49	15.37	6.27	8.24	2.21	1.48	2.34	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.10	14.43	4.86	5.02	2.43	2.27	2.27	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	15.07	9.62	5.77	7.38	0.96	2.89	3.85	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.15	15.35	5.12	9.29	2.08	2.37	3.60	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.76	15.66	6.33	5.06	2.21	1.90	2.69	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.72	12.47	7.91	5.17	2.43	0.91	2.74	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	16.10	17.35	5.85	7.00	1.67	0.94	3.35	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.88	13.83	3.51	5.05	1.98	1.98	2.85	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	16.83	10.66	2.81	4.49	1.68	1.12	2.52	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.76	23.33	5.46	7.13	2.31	1.11	3.06	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.58	17.11	6.69	3.21	1.07	1.07	2.41	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.27	22.80	7.65	4.59	2.91	2.60	2.91	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.17	20.08	4.27	5.96	1.17	0.91	2.85	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.35	17.89	5.15	4.88	3.25	1.90	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.01	10.69	4.98	6.45	2.40	1.11	2.58	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.06	8.33	6.14	5.70	1.54	1.54	3.07	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	20.83	10.91	8.93	0.99	3.97	5.95	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.72	12.27	4.88	3.56	1.58	0.66	1.98	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.72	8.47	3.43	5.65	2.02	0.40	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.82	24.40	11.95	15.25	6.61	3.81	8.13	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	50.76	10.95	3.38	3.58	2.99	4.38	4.38	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	51.77	14.95	3.70	4.01	3.08	3.24	3.54	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	62.81	21.07	3.07	6.14	4.09	5.11	3.68	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	28.79	14.39	4.07	3.13	3.44	7.82	5.95	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.15	10.45	3.96	1.70	2.54	6.22	4.24	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.20	11.99	5.07	2.77	4.15	4.61	3.69	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	7.42	0.00	2.47	2.47	9.90	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	39.45	12.76	7.74	3.48	4.64	6.96	5.80	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	6.42	11.23	1.60	3.21	3.21	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	10.43	5.22	0.00	5.22	6.96	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.76	9.76	5.21	2.60	4.56	2.28	2.60	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	27.18	14.82	6.18	3.71	4.53	3.29	4.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	13.33	10.00	6.66	3.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	7.83	4.75	3.64	3.64	4.75	3.92	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	19.61	14.38	3.27	5.23	3.27	2.94	3.27	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	30.20	8.39	7.55	5.87	5.03	5.03	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.27	14.95	5.73	2.23	4.13	4.77	3.82	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	22.08	11.55	3.40	1.36	1.36	4.42	2.72	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	10.44	4.18	4.18	2.09	4.18	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.92	10.31	4.01	10.88	2.29	2.86	4.01	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.24	9.18	4.74	2.07	3.26	3.55	1.78	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	5.08	1.69	5.08	0.00	3.39	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.64	17.40	4.97	4.14	3.73	5.38	3.73	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	17.95	8.74	5.75	2.99	2.07	2.99	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	0.00	0.00	0.00	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.61	7.69	3.08	1.92	4.23	3.84	1.92	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.78	11.41	5.22	3.91	2.61	1.30	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	7.36	2.01	2.68	2.68	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.34	8.09	2.70	3.47	1.54	1.54	5.01	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	17.46	10.61	4.11	2.05	4.11	3.42	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	2.48	4.97	2.48	2.48	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	24.06	7.08	4.72	2.36	4.25	0.94	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.73	6.03	2.41	4.22	2.41	4.22	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	8.65	3.56	3.56	3.05	2.54	2.54	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.94	8.77	5.18	4.39	2.39	2.39	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	9.87	8.39	2.96	3.95	2.96	1.48	2.96	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	11.80	2.36	1.18	4.72	0.00	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.00	8.75	2.92	3.50	2.92	4.08	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	17.56	7.02	3.51	3.51	5.71	3.95	2.63	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	12.72	3.39	2.54	3.39	3.39	3.39	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	11.94	3.58	4.18	1.19	1.19	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.79	6.31	3.88	0.49	1.46	0.00	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	9.13	2.28	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.14	3.33	1.25	2.08	2.08	1.66	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	22.49	4.50	2.25	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.66	4.12	1.90	1.27	1.27	0.32	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.76	2.09	0.42	1.25	0.42	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.99	8.59	1.97	2.20	1.04	2.09	1.28	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.72	10.63	2.03	1.86	1.86	2.19	2.03	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.66	8.42	2.50	1.82	1.82	2.96	0.68	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.85	8.42	2.51	2.84	1.53	2.19	2.08	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.48	10.32	3.01	2.58	1.07	0.86	1.07	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.87	6.03	3.01	0.86	0.86	2.80	1.08	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.33	7.10	2.86	2.12	0.75	1.12	1.37	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.44	6.52	1.89	0.51	1.89	1.37	1.03	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.17	7.05	1.60	0.64	1.92	1.60	1.60	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.27	13.43	5.60	8.95	2.80	2.24	6.72	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	43.71	17.31	6.92	17.74	3.46	3.03	8.22	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	7.93	2.64	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.45	12.35	1.76	9.52	1.41	1.76	2.12	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.25	5.81	2.18	3.63	0.73	2.91	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.67	4.37	2.10	2.80	1.40	2.10	2.27	0.87
Hepatocyte, donor1	11523-119I2	18.16	7.26	1.21	0.00	2.42	3.63	1.21	1.21
Hepatocyte, donor2	11603-120I1	21.55	18.31	2.15	1.08	1.08	6.46	1.08	0.00
Hepatocyte, donor3	11684-122I1	20.86	7.98	1.23	3.07	2.45	2.45	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	16.97	24.15	11.10	10.44	11.75	5.22	5.22	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.50	14.51	5.42	2.80	5.77	3.32	2.80	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.98	4.53	1.37	5.21	0.96	1.78	2.20	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	35.02	0.00	0.00	6.37	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	33.38	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	19.38	9.69	1.38	11.08	4.15	0.00	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	20.02	5.01	0.00	0.00	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	35.60	11.87	0.00	47.47	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	33.32	5.13	0.00	5.13	0.00	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	13.71	13.71	0.00	4.57	4.57	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	47.11	9.75	1.62	6.50	8.12	1.62	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	30.01	10.00	1.67	3.33	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	25.41	10.89	0.00	10.89	10.89	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	26.47	7.94	1.32	6.62	7.94	1.32	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	25.50	2.22	2.22	4.43	1.11	3.33	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	10.48	10.48	0.00	10.48	0.00	10.48	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.19	26.45	4.41	0.63	3.15	4.41	1.89	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	20.11	3.09	1.55	3.09	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	32.30	7.11	0.65	5.17	5.17	3.23	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	33.81	9.66	0.00	3.22	1.61	3.22	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	47.79	0.00	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	37.48	38.30	7.33	1.63	4.07	4.89	3.26	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	28.55	30.65	7.14	1.26	5.88	4.20	3.36	3.36
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	41.79	8.04	4.82	4.02	2.41	4.02	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	13.85	25.85	8.31	0.00	5.54	1.85	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	15.08	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.07	29.74	7.55	1.89	4.72	3.78	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	13.60	2.72	0.00	3.63	2.72	2.72	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	29.48	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	44.12	9.69	2.15	3.23	1.08	4.30	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	25.41	10.16	0.00	2.54	0.00	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	49.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	39.54	5.74	4.46	6.38	0.64	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	36.45	29.16	3.65	1.82	3.65	7.29	7.29	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	15.80	0.00	0.00	0.00	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.99	38.56	8.57	0.71	1.43	1.43	2.86	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	23.23	9.95	0.00	9.95	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	33.95	3.40	2.78	5.25	4.32	3.09	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	33.36	3.51	1.76	5.27	1.76	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	28.29	6.29	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	42.42	28.51	6.26	0.00	4.17	1.39	7.65	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	35.41	13.28	0.00	15.49	4.43	4.43	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	22.69	6.48	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	42.72	4.36	0.87	4.36	0.87	4.36	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	27.00	6.75	0.00	4.50	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	27.88	6.97	0.00	13.94	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	19.20	43.74	6.40	7.47	2.13	1.07	1.07	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	27.71	2.77	0.00	5.54	4.16	5.54	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	22.80	0.00	2.85	0.00	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	26.69	39.58	3.68	0.92	2.76	1.84	3.68	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	30.25	12.10	3.03	12.10	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	18.63	0.00	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	33.84	7.40	2.11	3.17	1.06	2.11	5.29
Keratinocyte - epidermal, donor1	11272-116H3	15.10	12.97	3.43	5.63	1.55	1.39	1.55	1.06
Keratinocyte - epidermal, donor2	11349-117G8	23.43	9.96	3.51	1.17	2.93	1.76	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	15.52	15.62	5.40	5.58	3.12	1.61	1.80	0.47
Keratinocyte - oral, donor1	11251-116E9	23.73	9.54	2.72	7.72	2.27	1.48	3.06	0.79
Keratocytes, donor1	11527-119I6	57.76	17.88	5.50	8.94	2.41	3.44	5.16	0.69
Keratocytes, donor2	11607-120I5	36.33	14.06	0.00	2.34	3.52	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	31.62	5.93	2.17	2.96	1.19	0.99	1.98	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	4.40	2.20	4.40	13.19	2.20	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	18.34	3.24	3.24	5.39	1.08	1.08	3.24	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.46	4.96	1.73	5.77	1.96	0.69	1.61	0.23
Lens Epithelial Cells, donor3	11690-122I7	14.23	4.94	1.92	3.94	1.72	1.41	1.92	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.38	10.08	4.51	3.08	3.08	1.54	2.13	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	6.70	3.07	1.95	0.56	1.95	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.28	11.18	4.41	4.25	1.10	1.57	1.57	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.37	4.30	2.15	2.69	0.54	0.54	2.69	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.03	6.62	3.47	3.15	0.63	1.89	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.89	7.98	3.99	3.45	1.40	1.29	1.73	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.67	6.98	4.10	2.87	2.05	1.64	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	7.84	5.31	1.52	2.02	1.26	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.53	9.01	4.36	3.66	1.69	0.84	1.27	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	7.52	1.58	3.96	1.58	1.98	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.95	6.40	4.65	2.71	1.36	0.39	1.16	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.03	9.26	2.78	2.59	2.04	1.48	1.67	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.15	7.67	4.18	4.18	1.05	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.26	7.16	4.05	1.91	2.15	1.19	1.67	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.28	8.38	4.67	4.26	2.33	1.37	1.51	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.32	7.70	2.16	1.23	2.16	1.23	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	4.68	4.05	3.43	0.62	0.31	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.55	12.26	4.76	3.84	2.01	1.83	2.56	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.61	4.28	1.32	3.95	0.33	0.99	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	9.37	2.34	2.93	0.29	0.88	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.70	9.71	4.98	4.73	2.49	1.49	2.49	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.82	5.33	1.94	1.94	1.45	0.97	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.04	8.89	2.96	2.96	1.08	1.89	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.35	10.14	3.63	3.48	1.97	1.36	1.67	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	7.78	1.04	2.59	3.11	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	10.89	4.19	3.35	1.47	1.47	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.89	10.83	5.41	3.76	1.50	1.50	2.56	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	8.94	3.44	0.69	2.75	3.44	2.06	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.65	6.59	2.26	2.26	1.69	1.88	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.19	9.22	4.14	3.18	2.23	1.48	1.70	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	7.27	3.39	2.42	2.42	1.94	2.42	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.94	7.94	5.62	1.65	1.32	1.98	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.03	10.04	3.22	2.60	3.22	2.11	1.86	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.70	10.00	0.37	3.33	1.11	0.74	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.42	6.18	3.46	1.73	0.74	1.73	1.73	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.86	7.97	2.61	2.47	1.65	1.51	1.51	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	12.54	1.29	4.18	1.93	2.57	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.83	9.43	3.04	2.43	0.91	2.13	1.52	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.22	7.98	4.76	4.06	2.10	1.82	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.02	5.33	2.84	3.56	1.78	1.42	2.13	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	7.76	5.82	1.94	0.97	1.94	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.80	8.87	4.98	2.80	1.40	1.24	2.18	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	12.18	3.94	2.15	0.72	2.15	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.05	7.19	4.25	2.29	1.63	1.31	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.36	7.06	4.71	2.12	2.35	0.71	3.06	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.08	13.37	3.09	4.58	1.86	2.85	2.85	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.99	8.71	2.56	2.31	1.54	1.28	1.79	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	13.72	10.74	4.77	3.58	3.28	0.90	2.39	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	13.60	22.66	0.00	4.53	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	26.85	16.11	3.84	8.44	2.30	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	19.30	14.84	3.71	7.42	2.23	1.48	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.46	28.77	19.89	3.39	5.08	5.08	1.27	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	17.58	21.80	2.81	13.36	2.81	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	17.75	16.81	0.93	5.60	0.93	0.93	5.60
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.24	27.82	15.46	2.06	7.21	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	29.74	8.33	2.38	7.14	1.19	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.31	21.94	12.67	2.94	7.46	4.52	0.68	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	7.27	25.59	14.83	1.45	6.40	2.33	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.60	16.66	11.70	2.25	7.20	2.70	1.35	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.11	36.58	17.07	4.88	8.94	3.79	2.03	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	28.24	15.41	3.08	7.19	3.59	1.03	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.41	20.82	10.94	2.82	8.12	2.12	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	16.66	13.33	4.00	3.33	1.33	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.24	42.28	16.30	3.06	9.17	4.58	1.02	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.67	25.88	10.94	4.27	6.40	4.00	0.80	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.96	28.53	14.55	2.08	4.72	4.53	1.70	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	19.63	14.11	1.84	10.43	4.91	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	30.99	13.86	4.08	13.05	6.52	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.00	32.07	12.49	2.71	6.66	4.16	1.25	2.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.73	25.22	14.85	3.08	8.69	2.52	0.56	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	31.94	15.46	8.24	12.36	5.15	0.00	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.77	25.55	22.06	3.48	9.87	4.06	0.58	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.88	28.40	13.45	2.99	5.08	2.99	1.20	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	30.43	9.96	1.66	5.53	2.77	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.14	39.24	24.04	4.95	9.19	5.66	1.41	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.11	26.92	14.38	3.32	8.11	4.79	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	29.93	14.97	3.45	8.06	1.15	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.59	35.69	16.50	3.45	9.59	5.76	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	36.80	9.06	2.26	10.76	3.40	3.40	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	28.72	9.85	4.92	9.85	4.10	0.00	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.01	36.15	20.33	2.71	9.49	2.26	3.62	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	22.26	7.90	4.31	7.90	5.03	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	18.67	31.37	13.44	1.49	6.72	6.72	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.84	41.25	20.07	4.09	15.24	4.09	1.86	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.32	18.09	14.65	1.72	3.45	2.15	0.86	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	31.68	17.13	3.43	8.56	4.28	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.66	29.65	15.66	2.33	11.33	7.33	1.67	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	28.96	24.13	1.81	6.03	3.02	0.00	6.64
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	22.75	9.95	2.84	8.53	6.40	0.00	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.72	32.65	16.84	1.72	8.59	3.78	2.06	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	23.08	14.49	2.68	7.51	4.83	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.12	26.26	13.47	3.37	5.39	4.04	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.22	34.82	18.52	3.70	11.48	4.82	1.85	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	22.10	9.30	1.16	9.30	9.30	2.33	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	17.98	23.27	3.17	9.52	2.12	1.06	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.61	37.21	13.20	2.80	12.40	3.20	2.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	38.52	14.54	3.63	10.90	2.91	0.73	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	26.83	17.63	3.07	8.43	6.13	2.30	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.33	37.49	15.78	3.45	7.89	4.44	2.47	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	42.34	22.58	0.00	10.35	2.82	0.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	27.66	21.12	3.52	11.56	4.53	0.50	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	27.49	24.33	4.51	12.17	7.21	5.41	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	24.10	20.65	0.00	6.88	8.61	1.72	8.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.02	27.17	27.17	3.56	14.25	6.68	2.67	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.78	37.15	22.68	3.13	14.86	7.04	1.17	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	21.11	16.49	1.32	5.94	5.94	1.32	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.05	36.84	21.28	5.71	6.75	6.75	3.63	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.44	42.01	20.13	4.81	13.56	7.00	2.19	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	32.99	20.13	2.80	7.83	7.27	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	39.31	20.76	1.77	7.95	9.27	0.88	6.18
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.41	36.26	18.51	4.24	12.73	11.57	1.54	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.10	29.37	13.67	2.53	9.62	8.10	1.52	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	30.76	17.78	1.92	12.02	14.90	2.88	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.53	34.19	18.68	2.78	11.13	9.14	0.00	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.11	35.24	16.41	3.65	13.98	7.29	0.61	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	24.21	8.99	2.08	6.23	2.08	0.69	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	12.92	36.10	18.62	3.04	11.02	8.74	3.42	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.81	38.73	24.27	2.58	7.75	5.68	0.00	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	33.86	15.72	4.23	9.67	9.67	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.04	43.73	20.92	4.44	13.31	10.77	2.22	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	44.78	25.06	1.60	11.73	8.53	1.60	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	35.05	10.34	2.30	12.64	10.92	0.57	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.97	55.02	25.71	3.09	14.40	7.20	2.06	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	44.56	23.34	0.00	14.15	6.37	1.41	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	38.59	17.59	2.84	10.78	9.08	1.13	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.22	40.77	27.04	1.66	10.82	7.49	0.83	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	48.55	20.36	0.78	5.48	9.40	1.57	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	29.23	15.87	2.51	7.10	6.26	0.84	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.19	44.61	15.80	1.86	14.87	4.18	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	29.44	20.07	0.67	12.71	6.02	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.97	43.31	18.18	3.74	12.83	6.42	2.14	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.01	51.72	17.78	3.23	14.14	8.49	2.02	5.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	27.53	24.78	2.75	12.85	8.26	0.92	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	30.23	16.00	0.00	8.00	8.89	0.00	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	45.59	21.66	7.41	12.54	13.11	2.28	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	34.51	19.94	0.77	13.80	5.37	2.30	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	32.28	18.06	2.19	13.68	9.30	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.39	40.09	20.49	4.45	10.25	9.80	1.34	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.98	38.47	20.02	4.68	13.52	11.18	3.12	4.42
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	31.83	15.91	1.99	15.91	8.62	3.32	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	24.94	27.02	4.16	16.63	10.39	8.31	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.40	18.23	8.66	5.24	4.33	1.14	0.91	1.14
Macrophage - monocyte derived, donor2	11313-117C8	10.64	11.93	4.95	5.14	3.67	8.99	3.30	0.73
Macrophage - monocyte derived, donor3	11389-118C3	11.01	15.99	7.21	5.64	4.72	5.64	2.75	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	2.12	3.19	0.53	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.41	7.13	2.85	2.06	2.85	0.16	0.48	1.43
Mallassez-derived cells, donor3	11930-125I4	15.71	8.76	1.81	1.81	1.67	0.56	0.56	0.97
Mammary Epithelial Cell, donor1	11273-116H4	19.73	13.05	3.19	3.19	1.40	2.19	1.49	0.40
Mammary Epithelial Cell, donor2	11350-117G9	17.08	9.27	2.61	2.03	2.03	1.45	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	19.70	11.97	2.00	2.49	2.00	2.74	1.50	0.25
Mast cell - stimulated, donor1	11487-119E2	28.47	27.12	6.78	0.68	3.39	4.75	1.36	0.68
Mast cell, donor1	11563-120D6	24.01	21.84	8.22	1.51	5.84	3.24	1.51	0.76
Mast cell, donor2	11565-120D8	51.71	16.34	14.86	3.27	11.00	4.16	1.19	2.97
Mast cell, donor3	11566-120D9	44.35	18.01	18.91	3.38	13.51	3.38	1.80	4.50
Mast cell, donor4	11567-120E1	49.64	19.86	13.30	3.55	9.93	7.98	1.60	2.84
Mast cell, expanded and stimulated, donor5	11940-126A5	30.83	15.97	5.99	0.89	4.88	1.66	0.55	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	25.10	11.67	0.00	4.67	7.00	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	20.19	12.16	5.05	0.69	3.10	0.57	0.23	0.57
Mast cell, expanded, donor8	11941-126A6	16.74	14.90	9.54	1.00	7.87	2.51	0.33	1.17
Melanocyte - dark, donor1	11502-119F8	15.82	7.46	4.48	3.78	2.09	1.79	2.39	0.90
Melanocyte - dark, donor2	11582-120F7	7.27	6.92	1.73	2.42	1.38	0.69	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	15.50	30.14	7.75	6.52	1.67	2.75	2.90	0.43
Melanocyte - light, donor1	11274-116H5	21.86	23.27	6.82	4.23	2.82	3.06	5.41	0.47
Melanocyte - light, donor2	11351-117H1	19.11	26.62	8.19	5.46	1.36	0.68	2.05	0.00
Melanocyte - light, donor3	11423-118G1	19.08	19.08	3.47	1.73	0.87	4.34	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	19.89	24.57	3.44	8.43	0.73	2.71	4.48	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	12.10	22.86	7.26	4.03	0.81	2.96	3.50	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	23.04	20.89	5.09	6.96	0.80	3.21	1.87	0.54
Meningeal Cells, donor1	11493-119E8	58.68	13.65	2.48	15.63	4.22	4.09	6.95	0.87
Meningeal Cells, donor2	11573-120E7	40.93	14.97	3.08	10.12	3.52	3.52	4.40	0.44
Meningeal Cells, donor3	11654-122E7	28.12	11.98	2.61	7.82	1.47	3.26	3.75	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.69	6.56	1.43	2.57	1.43	0.86	2.28	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.98	3.62	1.21	2.21	1.51	1.31	0.81	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	3.94	0.00	5.26	0.00	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	9.16	2.62	1.31	5.23	5.23	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	10.05	2.15	2.15	1.44	2.87	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.46	4.87	0.64	4.02	0.85	1.69	1.48	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.58	4.02	0.50	3.52	0.50	2.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	24.61	11.65	4.61	4.61	3.74	2.64	1.76	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	15.34	2.92	7.31	2.19	5.84	5.11	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.55	11.05	2.66	5.32	2.46	3.89	3.89	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7.06	2.91	1.39	1.66	0.55	0.42	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.15	10.04	3.72	2.23	1.12	1.12	1.86	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.68	6.05	1.32	1.05	1.05	0.66	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.06	5.64	0.59	1.78	0.00	0.89	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	9.34	2.34	2.34	2.34	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	26.90	7.04	1.92	5.76	3.84	2.56	3.84	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.39	7.44	1.06	3.19	3.54	3.54	2.84	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	2.81	1.88	0.94	0.94	0.31	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	5.81	1.45	2.18	2.18	2.90	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	9.81	3.98	1.33	5.57	1.33	2.92	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	16.01	3.00	2.50	5.00	0.50	2.00	2.50	0.00
Mesothelial Cells, donor3	11402-118D7	15.97	8.96	2.02	5.56	1.08	2.24	1.52	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	56.71	13.50	2.70	8.10	10.80	0.00	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.50	21.43	8.87	2.22	6.16	6.16	2.71	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.67	14.13	7.66	2.94	4.12	5.30	2.06	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	48.40	27.66	0.00	10.37	6.91	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	13.02	4.34	3.10	1.86	4.96	1.55	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.50	13.90	4.36	2.90	2.90	5.39	2.70	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	41.69	16.21	2.32	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.01	19.27	7.26	1.25	4.75	4.00	2.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.76	20.02	6.05	3.72	2.79	8.84	1.40	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.13	16.05	5.69	2.64	4.27	2.85	1.42	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.27	16.63	4.36	1.98	5.15	3.17	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	85.51	17.10	8.55	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	4.42	1.77	1.77	4.42	4.42	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.98	11.02	4.56	2.66	3.80	5.70	1.52	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	55.27	10.53	1.32	3.95	6.58	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.91	12.95	6.15	1.70	2.12	2.55	0.85	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	20.26	4.60	1.84	1.84	3.68	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.43	16.39	3.58	0.60	3.58	3.28	1.49	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	33.53	11.74	1.68	3.35	10.06	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	101.85	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.52	13.55	4.52	1.00	1.25	4.01	0.50	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	12.83	2.61	2.61	4.28	4.28	0.95	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	37.60	12.16	3.32	1.66	2.76	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.99	14.51	4.84	1.15	2.30	1.84	0.92	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.94	14.30	3.16	2.73	2.10	4.42	1.68	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	16.51	4.89	1.02	1.83	3.06	0.82	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.15	9.87	5.79	0.86	2.36	2.79	1.07	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.45	18.01	4.00	1.56	3.33	6.89	2.22	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	51.59	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.85	15.33	4.82	0.88	0.44	3.50	1.53	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.66	12.17	5.58	2.53	2.03	3.04	5.07	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	26.51	4.97	0.00	3.31	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	12.77	5.71	1.09	1.36	3.53	1.63	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.70	12.35	1.76	2.06	1.18	4.71	0.59	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	26.17	2.18	2.18	1.09	1.09	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	8.17	4.81	1.44	2.88	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	12.81	2.40	1.60	2.00	4.80	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	19.20	5.48	1.37	5.48	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	11.51	4.51	1.50	1.00	1.00	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	12.23	8.15	2.04	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	9.63	3.07	1.75	2.19	3.07	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	22.07	5.52	1.10	2.21	5.52	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	30.74	6.40	1.28	1.92	3.84	1.92	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.20	11.65	3.47	1.49	1.98	1.24	1.24	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	23.66	6.96	7.65	2.09	4.87	1.39	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	55.25	15.47	4.42	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.13	14.70	3.76	1.71	2.39	1.03	1.71	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.13	18.38	3.50	2.19	5.69	1.75	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	40.48	4.26	0.71	2.13	0.36	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.45	14.31	1.96	0.56	0.56	1.68	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.56	17.46	6.23	2.08	4.16	1.66	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	29.14	4.66	1.17	4.08	1.17	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	15.38	4.22	2.11	3.62	2.41	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	14.19	4.59	2.09	1.25	1.67	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	43.31	14.44	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	18.47	2.77	1.85	1.85	0.92	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	13.66	6.26	1.71	1.71	2.28	1.71	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.57	20.04	4.42	2.07	3.45	0.28	0.69	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.44	12.18	4.66	1.04	2.59	0.78	0.52	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.44	20.59	4.72	3.00	6.01	2.57	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	30.49	5.72	0.00	3.81	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.07	19.22	7.47	0.80	4.54	0.53	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	17.06	5.99	2.10	6.29	1.50	0.00	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.48	20.62	5.51	0.99	2.26	0.28	0.71	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.50	13.38	4.78	1.27	0.32	0.00	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.96	14.82	7.30	1.11	4.86	1.11	1.55	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	19.34	7.96	1.52	6.07	0.76	1.14	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.52	13.92	7.39	0.85	2.56	1.42	0.28	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.37	16.71	3.44	1.23	2.95	1.97	0.49	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	27.37	11.73	1.30	5.87	1.30	0.65	4.56
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	19.11	10.88	0.29	3.82	2.35	1.18	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	6.05	17.30	5.77	2.02	5.19	2.59	0.29	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	6.18	13.19	9.48	1.65	8.24	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.66	23.52	10.72	1.49	4.17	0.89	0.60	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	1.78	1.78	1.78	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.53	16.43	3.94	0.66	4.60	1.31	1.31	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	8.42	1.05	1.05	1.05	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.55	17.99	5.93	2.37	2.57	1.19	1.19	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	15.83	9.31	0.93	2.79	3.73	4.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.27	14.65	5.26	2.63	2.25	2.25	1.50	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.72	13.05	4.79	2.66	2.93	3.46	3.20	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.98	7.69	2.94	1.24	1.70	0.23	0.68	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	5.89	6.63	0.74	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	7.33	11.73	8.43	1.10	4.40	1.83	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	7.78	7.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	5.34	2.67	1.07	2.67	1.07	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	15.46	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	13.13	9.09	1.01	3.03	4.04	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	8.85	2.53	0.84	2.95	2.11	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	9.53	0.00	0.00	1.36	5.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.81	0.00	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	18.13	3.02	0.00	0.00	6.04	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	79.94	11.42	0.00	5.71	45.68	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	32.62	6.52	0.00	3.26	29.36	3.26	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	19.01	4.75	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	150.59	25.10	0.00	0.00	37.65	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.51	5.60	1.94	4.96	0.86	2.59	4.09	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.86	1.05	1.05	3.66	0.00	2.61	1.57	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	24.70	0.67	3.34	2.00	1.33	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	15.44	0.83	1.67	0.83	2.09	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.06	9.70	1.52	5.32	2.09	2.66	3.23	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	39.90	6.38	9.58	3.19	4.79	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	12.24	0.68	3.40	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	3.68	1.84	7.35	3.68	7.35	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	5.86	0.84	3.77	0.42	0.42	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	8.37	2.32	1.16	0.70	0.93	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.38	10.00	2.16	1.89	1.08	1.62	1.89	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.88	10.09	2.73	3.36	1.05	1.47	2.52	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	8.44	0.00	2.48	1.49	0.99	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.77	5.68	1.35	0.27	0.27	0.00	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	6.80	1.13	2.04	0.45	1.13	1.13	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.61	6.86	1.80	2.45	0.65	1.31	1.96	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.48	7.47	2.19	2.37	0.55	0.55	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.55	4.77	0.53	2.65	0.53	1.59	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	8.40	1.20	1.20	0.60	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	3.28	1.31	1.31	0.98	0.00	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.16	5.37	0.98	1.95	0.49	0.81	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.99	13.58	1.94	2.12	0.71	1.41	0.18	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	5.63	0.70	0.70	0.00	0.00	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	6.90	1.38	0.92	0.92	0.46	1.38	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.28	5.14	0.64	2.25	0.64	0.64	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.62	4.14	0.34	1.72	0.34	0.69	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	22.76	10.11	5.06	2.53	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.49	14.48	2.45	1.34	1.34	1.34	1.78	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.01	4.66	1.27	1.69	1.69	1.69	2.12	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.49	2.14	1.90	1.19	0.95	0.00	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	8.58	1.29	1.29	1.72	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.66	5.66	1.00	2.33	0.33	2.67	2.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	12.17	0.90	1.80	0.90	1.80	2.25	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	4.76	1.59	2.38	0.00	3.17	2.78	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	6.50	0.93	0.93	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.81	5.30	1.14	1.51	0.38	1.51	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.82	6.52	1.30	2.28	0.65	0.98	2.28	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	8.28	0.00	1.31	0.44	0.87	1.31	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	10.85	2.71	0.90	1.36	3.62	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	7.94	0.88	2.65	0.00	2.65	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	2.66	0.66	1.33	1.33	1.99	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.93	8.43	0.00	1.98	0.00	0.99	1.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	5.36	0.77	2.30	1.53	1.53	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	3.02	1.21	2.42	1.51	1.51	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.58	8.18	1.77	2.65	0.22	2.87	1.99	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	7.45	0.00	1.36	0.68	2.71	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	20.44	5.11	10.22	0.00	5.11	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	4.27	1.22	1.22	1.22	1.22	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	6.61	1.89	0.94	0.63	0.94	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.59	3.33	1.21	3.03	2.42	0.91	0.91	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	1.58	0.00	0.79	0.79	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	5.67	0.00	4.53	3.40	4.53	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	10.12	0.00	10.12	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	12.30	5.34	1.37	3.73	0.37	1.86	0.99	0.25
Myoblast, donor2	11322-117D8	18.22	7.67	1.34	3.84	1.92	4.03	2.69	0.58
Myoblast, donor3	11398-118D3	15.30	7.40	1.01	3.36	1.18	2.69	2.35	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	44.07	55.75	10.51	1.02	4.38	7.73	2.48	2.77
Natural Killer Cells, donor1	11230-116C6	57.81	33.21	23.37	4.00	9.23	6.15	2.15	2.46
Natural Killer Cells, donor2	11311-117C6	62.72	34.38	23.22	2.41	13.87	3.92	6.03	4.22
Natural Killer Cells, donor3	11387-118C1	67.55	34.42	25.40	4.97	10.86	5.15	6.44	5.52
Neural stem cells, donor1	11275-116H6	44.64	18.87	7.26	15.97	3.99	2.54	6.53	1.81
Neural stem cells, donor2	11352-117H2	40.44	15.41	7.70	9.63	7.70	1.93	13.48	0.00
Neurons, donor1	11494-119E9	29.59	5.69	2.28	15.93	2.28	2.28	0.00	0.00
Neurons, donor2	11574-120E8	18.49	3.52	1.54	10.13	0.66	1.10	3.30	0.22
Neurons, donor3	11655-122E8	21.38	13.98	0.82	6.58	3.29	4.11	2.47	0.82
Neutrophils, donor1	11233-116C9	2.78	42.69	55.68	33.41	51.04	2.78	4.64	17.63
Neutrophils, donor2	11314-117C9	0.00	31.89	57.98	28.99	60.88	0.00	2.90	20.29
Neutrophils, donor3	11390-118C4	3.67	47.03	84.30	29.32	80.02	0.61	2.44	14.66
Nucleus Pulposus Cell, donor1	11252-116F1	14.60	3.80	0.36	3.68	1.07	0.95	1.07	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	3.91	1.30	3.26	1.63	0.98	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.23	3.81	0.20	3.21	0.60	0.80	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	13.63	5.78	1.65	2.62	0.55	1.38	1.24	0.14
Olfactory epithelial cells, donor2	11934-125I8	14.47	4.63	1.88	2.32	1.45	1.59	2.03	0.14
Olfactory epithelial cells, donor3	11935-125I9	13.96	5.33	0.57	2.27	0.91	0.34	0.91	0.11
Olfactory epithelial cells, donor4	11936-126A1	16.75	8.38	1.07	2.24	1.07	0.97	0.68	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	9.03	4.81	1.81	6.02	0.00	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.04	4.68	1.28	3.62	1.70	2.34	1.91	1.06
Osteoblast - differentiated, donor2	11353-117H3	6.86	2.29	0.00	2.29	0.00	0.00	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	11.79	4.97	0.00	3.10	0.62	0.62	1.24	0.00
Osteoblast, donor1	11277-116H8	14.46	6.06	1.95	8.40	1.17	2.35	4.10	1.17
Osteoblast, donor2	11354-117H4	17.56	7.73	2.81	4.21	1.40	2.81	6.32	0.00
Osteoblast, donor3	11426-118G4	30.39	8.53	3.02	6.40	1.24	4.27	4.27	0.18
Pancreatic stromal cells, donor1	11249-116E7	15.25	4.89	1.52	2.53	1.26	1.94	1.52	0.34
Pericytes, donor1	11491-119E6	24.70	4.12	1.67	5.79	1.34	1.22	1.67	0.11
Pericytes, donor2	11571-120E5	29.43	7.02	2.72	6.56	3.40	1.13	0.91	0.91
Pericytes, donor3	11652-122E5	24.41	9.16	2.24	6.51	2.24	2.03	3.46	0.61
Perineurial Cells, donor1	11499-119F5	16.05	5.54	1.13	5.99	2.71	1.81	2.83	0.34
Perineurial Cells, donor2	11579-120F4	9.57	9.75	1.66	3.68	2.12	2.21	2.12	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.38	25.18	18.81	9.24	17.21	1.59	4.46	5.10
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	23.26	25.96	22.04	5.14	18.36	1.47	2.69	5.14
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	36.24	24.72	18.89	6.34	14.37	3.62	6.99	4.14
Placental Epithelial Cells, donor1	11278-116H9	10.04	10.04	4.07	4.07	2.87	3.59	2.15	1.43
Placental Epithelial Cells, donor2	11355-117H5	9.98	9.98	0.00	4.44	3.33	2.22	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	10.60	8.05	5.89	6.68	2.36	1.57	2.75	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.65	4.11	0.63	3.16	0.32	1.90	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	9.00	1.50	0.56	2.44	1.13	1.31	1.31	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.05	3.26	1.44	1.57	1.70	0.91	1.04	0.39
Preadipocyte - breast, donor2	11328-117E5	13.51	4.05	0.90	4.95	1.35	0.00	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	12.36	3.41	1.39	5.11	1.17	1.60	1.28	0.53
Preadipocyte - omental, donor2	11329-117E6	8.29	2.18	1.75	2.62	0.87	0.00	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	19.05	6.30	0.86	7.02	1.15	1.72	0.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	12.80	4.92	0.00	5.91	0.98	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	33.78	15.05	2.46	4.61	2.46	8.29	5.53	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	35.59	11.16	2.30	3.36	2.12	4.96	3.54	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	19.24	9.20	0.85	5.96	0.34	2.55	2.04	0.00
Preadipocyte - visceral, donor1	11280-116I2	25.52	11.46	2.24	4.47	1.02	2.42	1.96	0.09
Preadipocyte - visceral, donor2	11357-117H7	16.57	9.66	0.92	2.76	2.30	2.76	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.11	9.51	1.46	4.18	1.46	1.78	2.82	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.68	11.62	6.64	2.56	3.47	5.88	2.26	2.72
Prostate Epithelial Cells, donor2	11331-117E8	7.72	10.83	2.98	2.98	2.30	0.54	1.76	1.08
Prostate Epithelial Cells, donor3	11404-118D9	15.43	5.76	2.39	8.70	1.84	2.27	2.02	1.65
Prostate Stromal Cells, donor1	11254-116F3	14.81	6.38	1.71	2.05	0.34	2.39	1.82	0.23
Prostate Stromal Cells, donor2	11332-117E9	17.75	12.37	1.97	3.59	1.26	2.69	1.26	0.36
Prostate Stromal Cells, donor3	11405-118E1	12.93	5.84	1.36	2.71	0.73	1.04	0.83	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.58	11.68	6.20	7.30	5.11	2.19	2.92	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.23	7.07	3.74	7.14	3.26	1.59	1.59	1.52
Renal Epithelial Cells, donor1	11517-119H5	39.56	15.22	4.57	22.83	5.07	3.04	11.16	1.52
Renal Epithelial Cells, donor2	11597-120H4	25.61	9.96	2.13	13.52	1.42	2.13	7.11	2.13
Renal Epithelial Cells, donor3	11678-122H4	12.39	8.89	5.40	10.69	2.65	1.06	1.80	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.91	21.11	4.77	4.77	2.72	2.72	3.40	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	29.38	14.42	3.10	7.55	2.96	3.23	5.26	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.31	13.54	5.55	5.33	3.11	2.22	3.55	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	31.94	10.65	3.33	7.32	2.66	0.67	5.32	1.33
Renal Mesangial Cells, donor1	11518-119H6	23.55	10.34	4.40	9.24	1.76	1.10	3.30	0.44
Renal Mesangial Cells, donor2	11598-120H5	20.69	12.54	3.76	10.03	1.25	2.51	3.76	1.25
Renal Mesangial Cells, donor3	11679-122H5	18.03	10.26	5.55	9.15	2.50	1.94	2.22	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.33	13.96	5.64	4.83	4.03	1.34	5.64	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.51	11.81	5.06	8.43	1.69	1.27	2.11	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	30.28	24.49	3.86	8.29	5.01	2.70	6.36	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.48	3.89	3.89	6.74	3.37	2.07	1.81	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	20.18	10.23	3.41	5.97	2.27	3.41	3.13	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	13.38	2.06	2.06	3.09	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.04	4.52	2.01	3.76	1.00	0.50	2.76	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.04	12.70	5.35	6.28	3.61	3.47	1.47	2.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.93	31.27	8.04	0.89	2.68	1.79	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	14.86	3.30	1.10	2.75	1.65	2.20	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	9.28	27.26	8.70	1.16	5.22	0.58	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.45	20.41	2.21	1.56	1.95	1.56	1.56	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.24	30.19	3.77	1.69	1.89	1.29	1.39	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.42	27.77	5.35	2.12	2.68	2.68	2.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	24.56	31.63	3.23	1.74	3.97	1.36	0.99	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	23.66	34.38	3.61	1.52	1.28	1.52	1.98	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.66	46.69	5.32	2.08	1.85	2.08	1.39	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.39	21.08	3.97	1.37	2.60	2.19	1.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	21.18	29.20	3.18	1.36	2.12	1.21	0.91	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	19.53	31.00	3.23	1.97	1.79	1.79	1.61	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.35	19.22	3.16	1.43	1.58	1.15	1.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.96	30.16	3.54	1.40	2.68	1.07	1.29	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.55	39.39	2.66	1.99	2.88	2.43	1.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.34	19.12	3.06	0.76	1.72	1.15	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.61	35.22	4.29	1.40	2.05	1.86	2.52	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.98	32.70	5.83	1.32	1.88	2.25	0.94	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.25	23.49	3.05	1.59	1.86	1.46	0.93	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	26.87	36.70	4.48	2.04	3.31	1.65	1.65	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	27.12	35.33	4.01	1.91	1.34	1.72	1.91	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.15	24.67	3.20	1.28	2.67	1.50	1.17	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.27	26.35	5.61	0.00	3.92	1.68	1.40	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.58	38.79	4.10	2.05	2.56	2.05	1.54	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.40	21.70	4.19	1.46	1.82	1.82	1.46	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.56	32.62	4.78	1.59	1.96	1.10	0.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.18	41.10	3.90	2.96	1.75	1.75	1.48	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.98	12.27	2.36	0.94	0.94	0.94	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.00	31.15	3.97	0.99	1.79	1.79	1.59	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.45	30.63	4.44	1.17	1.64	0.70	2.34	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.76	19.91	4.15	1.24	2.28	1.45	2.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.35	30.53	4.20	1.33	2.65	1.11	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.48	34.67	3.55	2.51	1.67	1.67	0.84	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	18.03	19.92	2.83	2.42	2.15	1.08	1.21	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.20	35.76	5.45	1.87	3.07	1.19	2.38	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.45	41.45	4.24	1.16	2.12	3.47	1.54	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.54	19.77	3.09	1.38	1.72	0.34	2.75	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.26	33.74	3.84	1.78	2.88	0.69	1.10	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.49	31.68	6.24	1.15	1.81	1.31	1.31	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.08	21.82	4.26	0.85	3.07	1.36	1.02	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.19	32.70	3.85	1.63	3.11	1.48	1.63	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.26	43.71	8.26	0.53	2.67	1.87	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.21	24.20	3.87	1.66	1.66	1.11	1.66	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.52	37.14	4.05	0.95	1.67	0.24	0.48	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.14	59.66	10.68	1.21	3.43	2.42	0.60	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.91	23.64	3.96	1.04	1.51	0.94	0.66	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	13.28	45.42	5.94	1.75	0.35	1.05	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	15.72	42.31	6.35	0.91	3.63	0.91	1.21	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.79	24.48	5.51	0.49	1.35	0.12	0.49	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.97	62.88	16.01	2.33	2.91	1.46	2.47	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	6.08	40.76	5.48	0.00	3.04	1.22	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	8.14	24.71	3.01	1.81	0.90	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.44	27.82	6.33	1.13	2.49	0.90	1.58	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	7.79	44.93	8.99	1.50	4.79	0.60	0.90	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.68	23.73	3.31	1.42	2.24	0.83	1.18	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.11	30.95	2.77	1.07	1.28	1.28	0.85	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	8.41	43.27	7.21	0.60	2.40	0.60	1.20	1.20
Schwann Cells, donor1	11498-119F4	37.80	10.91	2.63	11.28	3.57	1.69	3.57	0.56
Schwann Cells, donor2	11578-120F3	10.21	3.40	0.00	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	13.14	5.70	1.53	4.60	1.97	1.10	0.44	0.66
Sebocyte, donor1	11220-116B5	48.20	35.06	6.57	9.31	2.19	2.74	5.48	1.64
Sebocyte, donor2	11301-117B5	26.65	17.92	4.60	5.97	1.38	2.30	2.76	2.30
Sebocyte, donor3	11378-118B1	25.35	11.13	2.27	7.21	2.27	1.86	1.03	0.21
Sertoli Cells, donor1	11255-116F4	13.25	6.63	0.00	0.00	0.00	1.66	4.97	0.00
Sertoli Cells, donor2	11333-117F1	8.47	0.00	0.00	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.79	5.19	2.02	7.21	0.97	2.46	2.99	0.44
Skeletal Muscle Cells, donor2	11358-117H8	9.40	6.51	0.00	5.78	2.89	3.61	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	31.77	12.54	2.51	7.52	3.34	3.34	5.02	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.89	8.64	1.41	4.56	2.36	2.20	2.67	0.47
Skeletal Muscle Cells, donor5	11455-119A6	19.32	9.36	1.49	5.80	1.78	2.68	2.68	0.00
Skeletal Muscle Cells, donor6	11459-119B1	30.01	9.54	1.85	4.31	2.15	3.08	3.69	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.88	6.68	2.65	7.06	1.01	1.39	2.27	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.84	7.71	0.86	7.42	0.86	1.43	3.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.14	12.00	2.78	7.74	1.19	3.47	3.37	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.21	5.90	2.11	7.84	0.67	4.13	3.20	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	50.66	9.41	2.90	3.62	0.00	2.90	2.90	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.58	4.95	0.83	6.05	1.10	3.16	3.03	0.14
Skin - palm, donor1	10286-104F7	18.80	56.41	10.74	2.69	8.06	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.78	6.20	3.17	2.16	1.01	1.01	0.86	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	15.54	21.27	12.27	0.82	4.09	0.82	2.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.79	8.18	1.95	1.30	1.43	1.82	0.78	1.17
Small Airway Epithelial Cells, donor1	11256-116F5	13.21	7.92	2.64	2.09	2.09	1.53	0.56	2.64
Small Airway Epithelial Cells, donor2	11334-117F2	21.66	16.46	4.50	1.55	2.11	3.80	1.27	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	18.82	37.21	12.48	3.81	8.46	6.13	2.11	3.38
Small Airway Epithelial Cells, donor3	11406-118E2	16.64	16.71	5.70	5.10	4.20	3.75	1.57	3.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.58	6.17	1.54	2.78	0.62	0.31	2.16	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4.00	3.56	1.11	2.67	1.11	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	12.34	2.94	5.29	0.59	2.94	2.94	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.26	13.92	2.21	2.65	1.55	5.52	2.65	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.63	13.78	4.33	3.94	1.97	5.12	3.54	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	38.63	12.36	0.00	5.41	3.09	3.09	3.86	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	1.00	0.00	0.00	0.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.43	7.45	2.40	3.99	0.80	2.79	1.60	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.74	6.43	1.11	3.32	0.89	1.77	2.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.05	7.04	1.54	4.35	1.15	3.58	1.66	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	11.07	3.26	1.63	2.28	1.30	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.04	5.91	2.66	4.13	1.48	1.48	1.77	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.25	5.98	1.42	2.99	0.57	1.42	0.43	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	31.07	8.62	2.44	6.51	1.30	3.74	2.11	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.96	3.96	2.74	6.09	0.61	2.13	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.19	10.36	1.01	7.32	0.76	1.52	2.27	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	159.14	36.72	12.24	0.00	36.72	18.36	18.36	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	12.87	0.48	3.34	1.91	1.91	1.43	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.14	5.31	1.03	2.21	0.74	0.88	0.88	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.90	5.81	1.29	2.80	0.86	0.43	1.94	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.53	6.72	1.89	4.09	1.36	1.26	1.57	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.33	13.30	3.09	7.27	1.24	5.10	3.71	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	21.56	8.62	6.47	1.08	3.23	2.16	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.32	10.16	2.09	4.18	0.90	1.79	1.20	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	36.53	12.97	5.12	6.15	3.07	5.12	4.44	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.03	4.48	1.10	2.83	0.71	0.39	1.02	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.40	8.05	2.62	4.83	1.81	2.11	1.81	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.71	11.83	1.37	1.37	1.59	0.91	2.50	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	22.34	14.49	1.81	1.81	1.81	1.21	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.65	9.54	2.91	6.09	1.59	3.44	5.03	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.58	4.79	0.80	2.80	0.93	2.13	1.07	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.02	9.39	2.00	2.13	1.13	1.63	1.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.86	3.30	0.51	4.31	0.25	1.27	2.79	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	27.29	10.10	2.11	5.88	0.45	6.03	2.71	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.01	4.50	2.25	4.50	0.75	3.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	178.33	27.14	5.17	6.46	18.09	10.34	7.75	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.55	13.95	0.47	6.51	0.47	3.72	2.33	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	6.56	3.03	1.51	2.52	3.03	2.52	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.74	15.98	0.63	2.51	1.88	2.19	2.51	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.40	5.90	1.77	3.83	0.29	0.88	2.65	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.74	10.66	2.92	4.92	2.25	3.92	3.42	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.74	5.61	0.93	1.87	0.47	0.93	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.03	11.08	1.73	5.76	1.44	2.73	2.88	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.36	15.55	2.04	3.82	1.02	2.55	3.82	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.89	11.85	2.07	4.70	2.26	2.82	2.63	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.91	5.45	1.12	4.89	3.49	0.84	0.98	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.72	3.60	1.26	3.18	1.01	1.09	0.67	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	4.29	1.43	2.38	1.43	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	11.01	2.69	3.91	1.47	2.94	2.45	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.25	6.41	1.55	5.52	0.66	6.85	1.77	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.83	2.34	1.76	1.46	1.46	2.05	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.75	4.66	0.39	2.72	0.78	0.58	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.37	5.02	1.59	2.91	1.59	1.06	2.12	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.32	1.49	1.12	0.74	1.49	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	5.75	1.08	2.87	0.72	0.72	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.75	5.68	1.42	1.14	0.85	1.99	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	15.36	3.15	1.18	3.94	1.18	2.76	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	9.14	2.79	0.51	2.29	0.76	1.27	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	9.98	2.80	1.20	1.60	0.40	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	4.18	0.42	3.76	1.25	0.00	2.93	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	6.88	4.13	0.00	2.29	0.46	1.83	0.92	0.00
Synoviocyte, donor1	11291-117A4	11.61	14.31	3.37	3.53	1.85	5.22	1.51	0.50
Synoviocyte, donor2	11368-117I9	11.73	5.20	0.84	3.02	0.34	0.84	0.50	0.50
Synoviocyte, donor3	11440-118H9	9.83	2.90	0.22	2.90	0.89	0.45	0.89	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	52.53	15.37	2.86	11.43	4.29	4.65	5.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	5.95	0.00	0.00	1.98	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	40.75	10.88	1.85	5.56	1.16	3.70	3.94	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	22.44	13.05	3.73	3.87	3.23	2.51	1.86	1.72
Tracheal Epithelial Cells, donor2	11369-118A1	14.69	15.46	3.48	1.93	2.71	1.55	1.16	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	22.33	12.03	2.29	1.15	2.29	2.29	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	15.13	12.55	3.94	7.75	5.04	3.57	2.21	2.83
Urethra, donor2	10319-105A4	17.98	12.59	7.19	1.80	0.00	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	18.33	16.74	6.91	5.58	5.31	0.80	1.06	2.39
Urothelial Cells, donor2	11600-120H7	14.42	12.82	5.21	4.01	2.40	2.40	1.60	2.80
Urothelial Cells, donor3	11681-122H7	11.92	12.84	4.13	6.65	3.21	2.29	1.15	1.83
Urothelial cells, donor0	11216-116B1	21.40	13.60	3.57	3.79	4.01	1.78	0.89	2.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	19.58	14.24	10.68	10.68	24.02	0.89	0.89	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	18.58	11.44	7.15	31.45	1.43	8.58	11.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	13.69	19.17	21.22	6.16	21.90	4.11	6.16	4.79
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.92	25.14	12.40	11.71	19.28	5.85	4.82	7.23
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	20.34	16.85	8.72	8.72	4.65	2.32	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	10.41	17.70	13.54	29.15	1.04	2.08	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	12.85	9.18	11.93	25.70	4.59	3.67	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	9.13	14.61	11.87	17.35	3.65	2.74	2.74
Wilms' tumor cell line:G-401	10809-111A8	29.98	28.87	4.56	2.10	1.36	3.45	1.97	0.37
Wilms' tumor cell line:HFWT	10597-108E3	44.88	19.36	7.04	7.04	1.76	10.56	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	17.32	15.64	6.42	7.26	3.63	1.96	1.96	1.40
achilles tendon, donor2	10292-104G4	14.47	22.73	6.20	4.13	10.33	8.27	0.00	10.33
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	40.03	23.20	8.92	2.55	3.82	6.88	4.59	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.24	28.33	3.25	6.50	3.25	3.95	5.57	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	46.06	49.74	13.18	7.48	5.94	3.92	5.22	1.66
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	40.00	25.31	9.80	14.69	5.17	13.61	11.16	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	61.00	14.90	8.99	8.15	6.46	4.22	6.46	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.95	8.88	10.79	1.90	8.04	4.44	3.38	2.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.90	16.88	11.43	4.90	14.97	6.26	4.63	8.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	31.29	15.86	5.73	3.08	2.20	2.20	3.97	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.06	8.17	6.94	4.08	11.43	3.27	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	36.89	32.62	5.05	3.49	10.87	4.27	5.44	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.79	17.48	4.78	3.50	5.15	4.60	3.86	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	50.71	11.70	3.90	19.50	0.00	3.90	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.31	23.01	7.20	3.72	4.18	6.51	4.88	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	72.49	29.51	7.51	4.40	8.28	3.11	3.11	3.62
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	38.28	20.16	6.72	4.38	4.97	2.63	2.92	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.87	16.27	9.30	3.25	7.90	4.18	1.39	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	33.31	30.84	8.64	0.82	4.94	0.82	1.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.19	31.00	6.45	2.15	8.59	1.53	1.53	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	20.06	32.43	8.53	1.71	6.40	2.56	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.11	26.39	5.16	2.43	4.85	0.91	1.82	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	18.53	31.05	7.46	2.65	7.22	1.68	2.65	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	29.62	14.70	5.79	3.34	4.45	5.12	2.45	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.69	25.02	13.34	4.00	9.34	8.67	7.34	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	174.67	94.77	5.57	13.01	16.72	14.87	13.01	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	77.97	34.65	13.94	15.82	9.42	15.07	19.96	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	63.24	31.40	14.83	13.96	6.98	10.03	6.98	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	26.24	1.87	1.87	3.75	0.00	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	18.84	26.61	4.47	1.65	4.47	0.71	0.47	0.94
adipose tissue, adult, pool1	10010-101C1	25.13	8.38	3.26	6.20	2.79	2.33	1.40	0.93
adipose, donor1	10184-103D4	30.49	5.86	1.17	4.69	3.52	2.93	0.59	0.59
adipose, donor2	10185-103D5	20.68	9.73	4.46	3.65	8.11	2.43	2.03	2.43
adipose, donor3	10186-103D6	27.23	12.53	8.71	5.45	6.81	3.54	5.45	2.72
adipose, donor4	10187-103D7	76.27	17.34	11.27	6.93	26.00	19.94	13.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.83	21.46	5.05	11.68	3.31	3.79	2.21	1.10
adrenal gland, adult, pool1	10081-102A9	18.19	3.64	7.28	7.28	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.02	8.00	6.27	1.47	5.60	1.20	0.80	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.08	14.65	0.36	2.14	0.00	0.71	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	16.69	5.56	3.71	10.67	2.78	4.41	3.48	1.62
amniotic membrane cells, donor2	12236-129G4	14.20	7.44	4.06	6.09	5.07	4.06	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	8.84	2.95	2.06	17.09	1.47	4.12	2.95	2.36
amygdala - adult, donor10196	10167-103B5	5.93	10.67	0.00	10.67	1.19	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	19.06	7.91	2.64	11.15	0.81	1.01	1.62	0.41
amygdala, newborn, donor10223	10360-105E9	11.62	8.07	1.29	4.84	1.29	4.52	1.61	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	33.11	9.80	5.98	8.53	3.82	2.42	2.16	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.48	16.99	2.87	1.99	1.32	6.84	3.31	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	14.70	4.34	4.34	0.33	1.67	5.34	0.33
aorta, adult, pool1	10052-101G7	20.01	20.40	4.12	7.26	5.49	2.16	1.37	0.98
appendix, adult	10189-103D9	34.54	23.29	5.43	2.72	5.43	1.94	4.27	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.16	10.66	3.78	1.03	1.72	1.72	0.69	0.00
artery, adult	10190-103E1	13.59	9.51	0.00	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	17.38	8.11	3.04	0.87	4.20	0.72	1.16	1.16
b cell line:RPMI1788	10427-106D4	32.42	8.77	3.57	5.80	2.38	2.38	1.78	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	12.76	3.88	3.88	5.27	0.55	2.50	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.79	18.16	5.06	2.08	1.49	1.79	1.09	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	5.52	4.02	2.01	3.51	1.51	1.34	1.34	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	20.13	7.83	1.68	7.83	0.00	3.36	1.12
bladder, adult, pool1	10011-101C2	23.79	6.08	3.04	3.48	3.48	1.96	0.65	0.87
blood, adult, pool1	10053-101G8	44.29	11.07	17.72	6.64	22.15	8.86	6.64	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	4.28	3.43	1.71	2.57	0.86	0.86	2.57
bone marrow, adult	10192-103E3	19.57	12.82	4.05	1.35	6.07	0.00	0.67	1.35
brain, adult, donor1	10084-102B3	23.58	5.13	1.03	4.10	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	14.92	3.12	1.45	8.02	0.89	0.67	1.34	0.22
brain, fetal, pool1	10085-102B4	18.70	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	9.25	25.44	13.54	3.63	8.59	2.97	2.97	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.72	22.34	8.99	4.24	4.37	2.37	2.62	0.87
breast, adult, donor1	10080-102A8	22.10	16.42	2.53	7.58	5.05	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.22	19.44	2.92	3.05	2.54	4.19	2.92	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	18.55	18.55	3.71	10.82	2.47	2.78	1.86	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.42	4.83	2.30	8.98	1.38	2.76	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.06	19.12	4.12	7.75	2.18	2.18	1.45	2.18
carcinoid cell line:NCI-H1770	10703-109H1	46.55	10.81	0.47	7.05	1.88	1.41	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	20.02	18.27	13.45	5.03	10.39	1.42	1.86	3.61
carcinoid cell line:SK-PN-DW	10719-109I8	32.64	10.77	1.90	5.39	0.63	4.44	3.80	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.68	22.36	1.60	5.86	1.86	1.06	2.13	0.27
caudate nucleus - adult, donor10196	10177-103C6	21.88	5.76	1.15	13.82	0.00	3.45	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	18.41	7.53	1.84	13.05	2.51	1.17	3.35	0.33
caudate nucleus, adult, donor10258	10379-105H1	17.58	8.41	0.76	10.70	0.76	3.06	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.45	5.49	1.46	3.66	0.37	4.03	1.10	1.83
cerebellum - adult, donor10196	10173-103C2	37.87	8.74	0.00	8.74	0.00	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	34.16	7.69	1.49	5.76	1.49	2.35	1.71	1.28
cerebellum, adult, pool1	10083-102B2	22.77	4.48	0.00	4.48	1.38	1.03	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	11.62	4.15	2.49	0.83	2.49	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	9.33	4.03	0.50	5.29	0.50	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	3.65	4.39	0.73	1.46	2.92	0.73	2.92
cervical cancer cell line:D98-AH2	10552-107I3	24.16	6.90	3.74	4.89	1.01	0.86	1.29	0.29
cervical cancer cell line:ME-180	10553-107I4	11.60	20.38	13.26	4.81	4.64	3.31	0.66	1.99
cervix, adult, pool1	10013-101C4	20.68	7.56	3.36	5.98	2.73	1.89	2.20	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.96	10.59	2.09	2.51	0.56	1.11	2.23	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	32.66	2.61	1.31	1.31	2.61	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	24.36	22.62	13.30	25.85	7.71	8.45	7.95	4.47
choriocarcinoma cell line:SCH	10785-110H2	10.84	15.16	6.28	7.52	3.20	5.67	3.70	1.97
choriocarcinoma cell line:T3M-3	10618-108G6	14.47	10.67	7.83	11.62	4.98	4.74	3.79	3.79
chorionic membrane cells, donor1	12238-129G6	6.84	4.84	4.27	13.39	3.70	4.27	1.99	1.42
chorionic membrane cells, donor2	12239-129G7	18.30	11.24	3.28	5.87	4.28	3.08	1.79	1.49
chorionic membrane cells, donor3	12240-129G8	11.54	10.44	2.75	13.74	5.49	7.69	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	18.18	2.02	4.04	1.01	2.02	5.05	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	36.88	22.28	5.96	5.76	3.07	4.99	4.03	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	52.59	33.79	6.55	3.17	5.70	8.24	3.59	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	33.38	36.98	7.96	1.80	8.22	5.39	2.57	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	39.91	38.46	7.98	2.90	9.19	4.35	5.56	3.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.58	32.17	5.50	3.87	11.81	6.72	5.29	4.89
chronic myelogenous leukemia cell line:K562	10454-106G4	53.00	22.67	4.71	2.36	5.01	6.18	3.83	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	77.93	40.66	13.29	5.21	8.34	11.21	10.16	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	6.40	2.97	0.23	0.91	1.14	0.69	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.15	5.38	2.60	1.56	2.08	0.35	1.04	0.87
colon carcinoma cell line:CACO-2	10513-107D9	21.05	12.08	4.58	5.67	3.48	4.76	1.10	1.83
colon carcinoma cell line:COLO-320	10420-106C6	36.87	16.72	1.90	7.22	2.28	0.76	2.66	0.38
colon, adult, donor1	10082-102B1	26.18	26.18	9.52	4.76	4.76	3.57	1.19	1.19
colon, adult, pool1	10014-101C5	33.14	12.81	3.76	7.52	5.05	5.29	3.29	0.59
colon, fetal, donor1	10070-101I7	14.83	25.34	4.94	3.09	3.09	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	59.59	64.17	22.92	64.17	18.33	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	18.27	23.80	5.52	0.85	2.12	5.95	0.42	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	17.21	14.79	3.77	1.66	2.41	3.17	1.36	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	23.69	26.65	3.81	1.55	1.27	4.09	0.99	0.42
corpus callosum, adult, pool1	10042-101F6	23.66	6.19	2.54	11.94	2.10	1.55	1.33	0.33
cruciate ligament, donor2	10295-104G7	17.83	23.50	8.92	4.86	4.86	4.86	7.29	2.43
diaphragm, fetal, donor1	10069-101I6	17.66	5.62	4.01	2.41	0.80	1.61	0.00	0.80
diencephalon, adult	10193-103E4	8.88	3.12	0.48	5.52	0.48	0.48	1.20	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	49.14	25.49	2.76	1.84	2.30	2.98	3.21	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.00	13.59	5.64	5.39	2.05	1.03	0.51	2.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.16	8.18	3.37	2.65	0.72	6.02	1.93	0.48
ductus deferens, adult	10196-103E7	32.89	17.44	1.00	2.49	2.99	2.99	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	24.48	0.00	1.44	1.44	0.00	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.18	14.71	7.36	2.94	5.15	2.94	2.94	1.47
dura mater, adult, donor1	10041-101F5	31.80	16.52	11.15	11.56	9.41	2.23	4.46	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.10	25.76	31.31	1.78	4.89	4.89	1.55	9.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.34	16.48	11.61	4.87	2.87	3.01	4.73	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	50.56	21.58	4.93	1.23	1.85	1.23	1.23	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	18.47	8.78	3.33	2.42	0.91	1.51	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.04	20.38	3.09	1.54	1.23	4.94	1.54	0.93
embryonic pancreas cell line:2C6	10603-108E9	30.21	22.33	9.19	1.31	0.00	2.63	2.63	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	50.28	20.11	11.73	2.01	4.02	5.36	1.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	30.63	23.92	5.44	15.95	1.45	2.90	2.54	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.59	18.98	10.94	2.89	2.25	0.64	1.45	1.45
epidermoid carcinoma cell line:A431	10426-106D3	12.45	14.45	6.45	2.89	3.22	4.11	2.67	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	28.60	16.83	5.17	3.19	2.75	3.19	0.99	0.88
epididymis, adult	10197-103E8	20.72	11.30	3.14	5.23	2.51	1.88	3.35	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.76	9.23	1.06	4.08	0.53	0.89	1.95	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.01	27.13	1.57	1.97	0.39	0.79	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	34.34	19.66	5.50	1.57	1.83	3.80	1.31	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.18	18.80	5.12	0.89	2.17	4.53	1.87	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	34.06	17.70	4.93	1.46	2.02	5.27	2.46	0.00
esophagus, adult, pool1	10015-101C6	16.25	9.98	2.76	4.88	2.34	1.91	2.02	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	28.55	0.50	0.38	7.39	0.63	4.38	3.51	0.25
eye - muscle inferior rectus, donor1	10272-104E2	16.90	9.66	7.24	4.83	2.41	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	6.31	6.31	0.00	4.21	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	32.74	14.88	0.00	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	29.81	13.76	5.73	1.15	5.73	5.73	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	30.61	11.66	2.91	5.83	1.46	1.46	2.91
eye, fetal, donor1	10054-101G9	17.80	3.81	1.02	4.07	0.76	2.03	1.78	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	21.67	11.16	1.28	5.39	1.03	3.72	2.95	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.00	23.50	5.70	5.94	4.51	3.80	2.14	0.95
frontal lobe, adult, pool1	10040-101F4	15.76	3.85	0.94	8.54	0.75	0.38	1.31	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.81	21.92	11.11	3.90	3.30	1.50	2.10	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.35	9.97	2.93	4.48	1.46	0.73	0.64	0.27
gall bladder, adult	10198-103E9	23.66	10.62	3.86	4.35	3.62	1.69	1.69	0.24
gamma delta positive T cells, donor1	11937-126A2	41.34	23.62	9.66	5.37	9.66	4.29	6.44	1.61
gamma delta positive T cells, donor2	11938-126A3	52.29	25.77	12.70	4.86	12.70	4.48	5.23	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	25.77	6.97	1.69	3.38	2.53	3.38	1.27	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	32.11	20.89	7.35	5.42	2.32	3.67	2.13	0.58
gastric cancer cell line:AZ521	10549-107H9	33.28	25.74	5.90	2.79	1.31	2.95	2.13	0.33
gastric cancer cell line:GSS	10560-108A2	11.90	10.07	1.83	6.41	1.83	0.92	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	22.39	9.37	2.74	2.74	3.20	1.37	0.91	2.51
giant cell carcinoma cell line:LU65	10487-107B1	26.73	8.03	1.38	1.26	1.03	2.64	1.49	1.38
giant cell carcinoma cell line:Lu99B	10433-106E1	16.52	14.00	4.20	7.98	2.10	2.66	3.08	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.22	15.96	3.74	2.24	2.74	0.50	1.00	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.57	16.04	3.17	4.54	1.06	1.37	2.74	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.70	18.82	1.69	5.48	1.26	2.25	2.95	0.56
glioblastoma cell line:T98G	10485-107A8	17.44	9.71	2.76	2.21	2.10	1.10	2.65	0.33
glioma cell line:GI-1	10413-106B8	17.28	12.01	2.64	2.34	0.29	0.29	2.34	0.00
globus pallidus - adult, donor10196	10175-103C4	17.49	8.75	1.46	8.75	0.73	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	35.39	8.79	2.44	9.03	3.66	3.42	1.22	2.20
globus pallidus, adult, donor10258	10367-105F7	9.58	1.37	1.37	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	4.26	3.73	3.73	2.66	5.33	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	151.72	85.65	68.52	0.00	46.50	14.68	9.79	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	10.93	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.76	11.20	1.92	3.20	1.60	1.60	1.28	1.92
hIPS +CCl2, biol_rep1	14383-156B9	38.11	9.18	5.97	3.21	7.35	5.97	5.97	2.30
hIPS +CCl2, biol_rep2	14384-156C1	42.07	7.32	5.03	1.83	2.74	3.20	3.66	1.37
hIPS +CCl2, biol_rep3	14385-156C2	34.14	3.22	5.80	3.86	1.29	3.86	3.22	1.29
hIPS, biol_rep1	14380-156B6	18.68	1.44	4.31	0.00	2.87	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	23.32	6.17	5.49	2.74	3.43	0.69	2.06	0.69
hIPS, biol_rep3	14382-156B8	15.45	3.31	2.21	3.31	2.21	0.00	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	25.57	13.51	5.46	4.02	1.15	5.17	1.44	0.29
heart - mitral valve, adult	10205-103F7	24.81	10.16	1.20	3.59	1.79	2.39	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	21.96	10.20	2.35	4.18	1.57	1.05	1.31	0.78
heart - tricuspid valve, adult	10207-103F9	71.61	22.48	5.83	1.67	2.50	8.33	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	16.94	11.22	2.24	2.65	1.22	0.82	2.04	0.20
heart, adult, diseased, donor1	10051-101G6	20.01	9.37	3.41	2.13	3.41	1.28	0.85	0.00
heart, adult, pool1	10016-101C7	29.44	4.83	1.61	2.53	2.07	2.07	2.30	0.46
heart, fetal, pool1	10046-101G1	24.23	6.98	2.77	4.00	3.18	2.26	0.92	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.35	10.49	1.54	2.16	1.23	2.47	0.62	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	10.70	7.14	2.38	3.57	4.76	2.38	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	34.47	26.52	6.96	1.10	4.31	3.43	2.10	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	38.11	30.46	8.25	2.06	4.01	4.13	2.06	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	39.21	26.88	9.09	2.02	3.94	4.85	3.44	1.41
hepatoma cell line:Li-7	10484-107A7	14.12	10.45	4.45	0.56	2.45	2.11	0.33	1.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	44.42	23.52	5.63	4.72	2.61	6.63	4.42	0.30
hippocampus - adult, donor10196	10169-103B7	15.14	5.68	1.89	19.87	0.95	1.89	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	28.57	8.98	2.65	16.74	2.04	2.25	3.06	1.22
hippocampus, adult, donor10258	10374-105G5	6.97	1.49	1.00	4.98	1.00	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	16.92	6.34	2.82	7.05	0.70	3.17	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.17	7.32	4.27	6.10	6.10	9.16	4.88	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.10	13.94	6.28	7.07	3.73	9.23	7.07	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.04	13.46	5.84	8.38	4.32	7.62	4.32	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	7.33	2.26	3.95	2.82	3.95	1.69	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	8.52	2.32	3.61	7.49	0.77	2.32	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.30	8.73	1.90	0.76	4.18	1.14	2.28	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	20.73	13.43	6.42	4.38	4.38	2.04	1.17	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.70	18.74	10.99	4.74	3.02	2.15	1.94	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.93	20.02	5.84	4.59	2.09	4.59	2.50	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.34	8.05	3.79	4.26	1.18	2.60	1.89	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.14	17.04	8.36	6.91	3.21	2.73	3.21	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.87	9.43	7.41	7.41	0.67	1.35	4.04	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.11	9.55	3.76	4.23	2.19	6.26	4.69	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.43	8.35	4.91	3.93	2.46	4.42	4.91	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	6.11	2.62	5.24	1.75	2.62	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	28.64	10.50	3.44	2.48	3.25	1.34	1.34	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	22.24	10.03	1.31	3.92	3.92	3.05	3.05	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	4.50	5.50	3.00	2.00	1.00	3.50	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.98	8.29	5.46	4.90	3.39	2.45	2.07	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.28	10.00	5.91	4.09	2.27	3.18	1.82	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.60	9.71	5.33	2.82	3.76	2.82	0.00	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	18.29	5.39	2.78	4.74	1.96	2.29	2.61	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.52	4.94	1.74	4.06	0.58	0.87	1.74	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.82	4.78	3.59	3.89	1.79	0.60	2.09	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	29.00	15.33	6.28	4.62	3.69	6.10	3.33	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	41.65	12.84	6.85	3.42	5.71	6.56	3.42	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.44	12.25	7.76	4.90	6.53	5.72	3.67	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.00	8.80	5.28	4.58	2.46	2.46	3.52	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.17	10.77	5.07	4.12	4.43	2.53	2.53	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	5.75	3.63	2.42	4.84	3.03	2.12	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	10.34	5.69	4.14	3.62	4.14	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	7.97	2.66	4.65	3.32	1.99	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.62	8.47	3.59	3.85	2.05	1.80	1.03	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	5.37	2.05	3.07	1.28	1.79	3.07	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	11.36	6.06	4.54	3.79	3.03	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.82	7.06	2.35	5.04	3.02	3.36	3.02	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.50	11.11	4.59	6.52	5.31	6.28	3.86	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	26.29	8.91	7.13	4.46	3.57	4.01	3.57	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	34.63	11.71	6.34	5.85	4.39	7.80	2.44	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.06	8.56	2.44	3.06	4.28	1.83	1.83	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	3.25	3.25	6.51	0.00	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.83	9.93	3.31	4.30	4.96	2.32	1.65	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	13.14	4.38	3.28	3.83	3.28	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.56	9.05	5.43	2.17	3.62	2.17	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	10.68	8.19	2.14	1.78	2.14	1.42	0.71	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	5.97	3.58	2.39	2.39	3.58	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.83	7.45	5.28	5.96	2.71	1.76	3.66	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.70	7.27	5.12	5.66	1.62	2.16	2.42	0.81
immature langerhans cells, donor1	11904-125F5	13.56	21.55	25.67	4.12	9.93	3.15	1.21	4.60
immature langerhans cells, donor2	11905-125F6	14.26	26.93	12.67	8.71	9.51	7.92	2.38	3.17
insula, adult, pool1	10039-101F3	19.12	5.11	1.32	11.36	1.14	1.04	1.89	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	5.20	13.33	2.60	2.93	1.30	0.00	1.95	0.33
kidney, adult, pool1	10017-101C8	20.03	16.72	5.01	9.11	4.11	2.90	3.10	0.80
kidney, fetal, pool1	10045-101F9	22.49	13.58	7.36	9.62	7.29	3.47	3.25	2.19
large cell lung carcinoma cell line:IA-LM	10509-107D5	37.07	4.83	3.12	3.98	4.69	2.13	2.13	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.82	3.46	0.55	1.38	0.55	0.55	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.68	18.90	8.26	1.47	4.77	2.94	1.10	4.40
left atrium, adult, donor1	10079-102A7	13.08	3.27	2.18	2.72	2.18	2.18	0.00	0.54
left ventricle, adult, donor1	10078-102A6	18.71	6.07	1.01	2.02	2.02	0.00	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	38.03	22.16	1.64	2.46	1.64	3.01	3.28	0.00
leiomyoma cell line:10964C	10569-108B2	13.65	5.75	1.08	2.87	0.36	0.36	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	8.70	4.35	0.00	4.35	0.00	1.09	2.72	0.00
leiomyoma cell line:15425	10571-108B4	10.68	3.16	2.19	3.64	0.24	2.91	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	29.28	7.32	1.05	1.05	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	80.87	29.75	18.65	6.97	6.73	6.26	8.38	1.06
liposarcoma cell line:KMLS-1	10782-110G8	13.59	6.40	0.94	2.97	1.09	1.56	0.62	0.16
liposarcoma cell line:SW 872	10726-110A6	26.20	18.89	5.36	2.07	2.68	1.22	1.46	1.22
liver, adult, pool1	10018-101C9	35.49	12.15	2.27	2.92	1.94	6.16	1.30	0.65
liver, fetal, pool1	10086-102B5	12.23	11.29	4.70	3.76	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.23	10.94	4.37	7.44	2.48	4.23	1.46	0.87
locus coeruleus, adult, donor10252	10165-103B3	25.47	6.27	1.66	4.80	1.85	2.77	1.48	0.92
locus coeruleus, adult, donor10258	10375-105G6	8.75	3.67	0.56	6.21	0.56	1.13	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	13.88	4.21	1.26	4.21	2.10	4.21	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	9.00	5.12	0.83	1.38	0.97	1.38	0.69	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	20.68	8.27	4.83	4.83	2.07	2.76	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.69	15.16	3.03	3.56	1.45	0.40	0.79	0.26
lung, adult, pool1	10019-101D1	23.39	14.65	8.03	7.21	8.51	3.90	2.95	2.95
lung, fetal, donor1	10068-101I5	21.12	9.70	4.28	7.42	7.99	2.85	3.42	3.71
lung, right lower lobe, adult, donor1	10075-102A3	18.33	15.12	5.04	5.50	4.58	1.83	0.92	0.92
lymph node, adult, donor1	10077-102A5	24.61	21.30	3.31	4.73	6.15	1.89	3.31	0.95
lymphangiectasia cell line:DS-1	10727-110A7	21.92	12.05	3.51	2.41	2.41	1.97	2.41	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	33.35	37.13	6.19	1.36	1.66	2.41	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.04	7.65	6.80	1.70	2.55	5.10	1.70	0.85
mature adipocyte, donor1	12231-129F8	27.08	5.33	2.22	6.66	1.33	5.77	2.22	0.89
mature adipocyte, donor2	12232-129F9	23.66	8.51	4.36	6.85	1.87	5.19	1.25	1.25
mature adipocyte, donor3	12233-129G1	21.57	9.48	3.56	7.59	0.47	4.50	0.47	0.95
mature adipocyte, donor4	12234-129G2	20.27	4.74	2.11	3.16	2.11	2.90	1.58	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.20	13.10	5.00	5.72	4.29	1.19	1.19	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	4.51	0.00	4.51	0.00	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	16.92	4.41	2.76	8.28	2.02	2.02	0.74	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	13.66	2.86	0.95	5.40	0.32	0.64	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	11.09	5.12	1.28	1.71	1.71	2.56	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	18.39	4.89	2.19	9.79	0.68	2.36	1.86	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	25.68	7.00	1.06	8.06	1.70	1.91	1.91	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	0.00	1.93	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	11.13	4.67	0.00	3.95	0.36	5.03	0.72	3.95
medulla oblongata - adult, donor10196	10174-103C3	21.42	11.03	2.60	11.03	0.00	3.89	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	23.99	10.53	2.79	6.35	4.02	3.41	1.39	0.31
medulla oblongata, adult, pool1	10038-101F2	22.94	9.22	2.61	10.69	2.20	2.12	1.22	0.49
medulla oblongata, newborn, donor10223	10361-105F1	9.72	3.47	4.17	4.86	2.43	4.17	1.04	2.08
medulloblastoma cell line:D283 Med	10838-111E1	34.98	9.52	3.10	16.83	2.66	6.20	6.86	0.66
medulloblastoma cell line:ONS-76	10759-110E3	47.20	17.61	3.67	3.42	2.45	3.30	3.06	0.61
melanoma cell line:COLO 679	10514-107E1	21.27	13.37	4.17	3.31	0.72	5.03	4.02	0.57
melanoma cell line:G-361	10465-106H6	36.38	13.30	1.90	5.70	1.90	3.53	2.44	0.81
meningioma cell line:HKBMM	10691-109F7	30.03	5.25	1.63	1.45	1.27	0.72	0.54	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	39.65	22.03	10.57	7.05	3.52	6.17	4.41	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	39.40	14.52	7.78	5.70	2.59	2.59	4.15	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.49	7.83	1.69	6.44	1.23	1.99	2.92	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	6.91	0.55	3.82	1.27	2.36	2.73	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	3.31	0.83	2.90	0.41	1.66	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.03	9.13	1.26	1.55	0.42	1.26	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.60	4.04	1.35	2.70	0.39	0.58	1.16	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	4.16	2.78	1.39	0.69	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.64	7.04	1.89	2.40	1.72	1.20	1.37	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.80	5.75	0.81	4.26	1.27	2.76	2.76	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.30	9.28	0.93	4.64	1.19	1.86	3.05	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.20	8.24	1.89	2.43	1.49	1.76	1.08	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.62	10.53	2.56	3.98	1.28	1.99	1.99	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.22	6.92	1.32	1.98	1.65	1.32	1.32	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.02	7.75	1.80	2.77	2.49	2.35	2.08	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.99	5.24	0.70	2.79	1.05	1.40	2.79	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.47	3.88	0.20	5.92	0.82	1.43	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	9.35	1.44	3.95	2.52	1.44	3.24	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.14	2.38	0.62	3.00	0.52	0.41	1.24	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.70	4.79	1.37	3.88	0.91	0.91	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.62	5.45	2.52	4.62	2.52	2.10	2.52	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.50	5.38	1.49	2.69	1.49	2.24	1.79	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.59	8.05	1.75	3.15	1.58	1.23	1.49	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.57	10.31	1.10	4.42	1.10	2.21	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	8.30	2.86	2.86	1.14	3.15	1.43	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.42	12.21	2.11	4.21	0.84	0.84	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.42	4.57	0.00	2.28	0.46	0.00	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.79	2.05	1.79	1.53	0.00	1.28	2.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.66	3.93	2.62	3.14	0.26	2.36	2.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	2.77	0.31	3.39	1.23	1.54	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.30	1.65	1.41	2.35	0.71	1.18	1.41	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	2.03	0.68	2.03	1.02	3.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	4.32	0.79	3.54	0.79	1.18	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.73	2.32	0.93	3.24	0.93	0.93	3.24	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.59	5.19	1.15	3.75	1.73	1.15	2.88	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.16	2.01	0.89	3.35	0.45	1.34	1.78	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.62	4.09	0.96	3.36	0.96	1.68	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	4.40	0.73	6.60	2.20	4.40	4.40	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.41	4.03	0.34	2.35	1.01	1.01	2.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	4.09	0.41	2.05	0.41	1.23	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	3.87	0.86	4.73	0.43	2.15	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	5.47	0.00	5.47	2.73	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	5.16	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	3.90	0.97	3.57	1.30	1.95	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	1.45	1.45	1.45	1.45	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.13	4.26	1.07	1.07	1.07	2.67	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	1.64	0.82	4.09	0.82	3.27	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.88	2.33	0.00	2.72	0.39	1.17	3.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	6.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	2.98	0.99	0.00	0.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	9.53	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	4.15	0.00	4.15	0.00	1.19	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	4.87	1.22	3.66	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	0.63	0.63	1.27	0.00	0.63	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	2.41	1.03	1.72	0.34	0.69	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	0.00	0.00	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00	0.00	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	3.26	1.22	2.04	0.00	0.41	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	2.38	0.00	1.59	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	4.13	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.30	4.05	0.00	0.94	0.00	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	4.01	1.34	2.67	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	3.55	0.00	1.18	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	0.00	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	6.20	0.69	2.07	0.69	2.75	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	3.96	0.00	2.97	0.99	0.49	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	3.36	0.00	1.12	0.00	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	2.54	0.64	1.27	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.69	2.42	0.81	1.21	0.00	0.81	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	6.54	2.18	0.00	0.00	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	5.07	1.27	1.27	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.10	4.25	1.21	2.43	0.61	0.00	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	6.59	3.29	2.47	0.00	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.14	3.37	0.60	0.99	0.60	0.99	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.52	2.27	0.32	0.65	0.97	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	4.07	1.02	1.02	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	20.89	5.42	8.51	1.55	3.87	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	20.55	14.41	6.14	11.81	2.60	2.83	2.36	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.75	7.88	1.85	6.26	2.55	3.24	2.32	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	17.09	4.27	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.89	3.19	2.26	2.16	0.62	1.23	0.82	0.31
mesothelioma cell line:Mero-25	10850-111F4	43.12	9.08	7.04	4.99	6.81	1.13	1.59	2.27
mesothelioma cell line:Mero-41	10851-111F5	32.76	18.58	3.42	3.67	2.69	2.44	3.18	0.73
mesothelioma cell line:Mero-48a	10852-111F6	22.14	7.97	2.21	2.21	1.11	1.77	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	31.80	14.45	4.99	2.89	2.10	4.47	1.84	1.84
mesothelioma cell line:Mero-83	10854-111F8	31.15	8.34	2.04	3.23	1.70	2.72	2.04	0.51
mesothelioma cell line:Mero-84	10855-111F9	18.20	9.35	0.51	2.53	0.76	1.26	1.26	0.25
mesothelioma cell line:Mero-95	10856-111G1	15.74	7.87	0.62	2.48	0.83	0.83	1.24	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	22.36	19.55	4.80	7.12	1.33	2.15	2.15	1.33
mesothelioma cell line:NCI-H226	10846-111E9	20.81	12.67	2.53	1.45	1.45	0.90	0.72	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	20.84	10.42	3.93	5.30	3.25	2.90	2.90	0.51
mesothelioma cell line:NCI-H28	10845-111E8	15.52	7.63	3.31	3.31	4.83	2.29	3.56	1.02
mesothelioma cell line:No36	10857-111G2	21.53	13.70	4.89	2.94	3.59	2.28	1.96	0.33
mesothelioma cell line:ONE58	10858-111G3	12.46	13.01	5.42	1.35	0.81	0.81	1.63	0.27
migratory langerhans cells, donor1	11901-125F2	18.42	8.25	3.45	4.80	4.41	0.19	0.58	1.15
migratory langerhans cells, donor2	11902-125F3	15.39	15.88	4.40	4.76	6.23	0.49	1.10	0.37
migratory langerhans cells, donor3	11903-125F4	21.18	13.10	4.85	3.77	5.92	0.54	0.54	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.34	8.16	2.94	2.29	0.98	1.31	1.31	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.68	3.60	1.91	1.06	1.91	0.85	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	24.65	26.72	7.83	2.99	4.84	3.69	1.61	3.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	21.50	8.94	4.19	1.71	2.66	0.76	1.14	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.02	24.02	13.12	2.40	8.50	3.51	2.77	1.11
myeloma cell line:PCM6	10474-106I6	33.60	10.67	1.38	0.99	0.99	1.58	1.19	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.32	8.12	2.03	0.51	1.01	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.38	16.67	2.75	0.98	2.75	1.77	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.59	6.80	2.79	2.90	1.89	1.56	0.56	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.99	5.66	1.91	2.65	1.91	1.10	0.59	1.32
nasal epithelial cells, donor2	12227-129F4	29.26	12.70	4.42	5.52	10.49	9.94	4.42	0.55
neuroblastoma cell line:CHP-134	10508-107D4	63.50	14.49	3.68	3.68	2.07	2.99	2.99	0.92
neuroblastoma cell line:NB-1	10539-107G8	42.47	7.48	3.37	5.80	1.31	2.25	3.74	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	32.06	6.75	2.95	3.37	2.11	1.48	1.90	1.27
neuroblastoma cell line:NH-12	10555-107I6	56.65	5.96	2.80	5.40	2.42	3.35	4.10	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	22.06	2.37	3.08	8.30	3.08	2.61	4.74	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.25	5.54	5.07	9.66	3.48	7.13	4.59	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	52.33	14.69	4.23	5.84	2.01	7.45	7.45	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	59.76	11.44	6.36	14.62	1.27	8.90	13.99	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	24.22	6.12	0.27	3.99	0.27	3.73	2.93	0.53
neutrophil PMN, donor1	12133-128D9	0.00	119.00	104.12	0.00	44.62	29.75	14.87	44.62
neutrophil PMN, donor2	12137-128E4	0.00	53.12	53.12	0.00	13.28	0.00	0.00	26.56
neutrophil PMN, donor3	12141-128E8	0.00	18.94	9.47	0.00	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	27.06	22.32	9.13	5.41	16.57	3.38	3.55	3.55
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.01	3.20	2.40	5.60	0.80	0.80	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.94	5.77	0.96	2.24	0.00	1.60	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.88	6.04	2.63	0.26	0.00	0.53	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	18.84	5.91	0.94	11.81	1.03	1.41	2.44	0.37
occipital cortex - adult, donor10196	10172-103C1	16.48	6.18	0.00	8.24	2.06	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	27.64	10.73	4.03	9.93	3.22	3.49	3.22	1.61
occipital cortex, newborn, donor10223	10355-105E4	10.92	4.37	1.09	4.37	1.09	4.00	1.46	3.28
occipital lobe, adult, donor1	10076-102A4	17.06	5.51	0.52	9.97	0.79	2.10	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	21.03	5.15	1.29	5.58	0.43	0.43	2.57	0.86
occipital pole, adult, pool1	10036-101E9	18.76	3.15	1.02	9.62	0.95	1.02	2.37	0.08
olfactory region, adult	10195-103E6	14.14	5.73	0.76	6.50	0.96	0.76	1.53	0.19
optic nerve, donor1	10277-104E7	18.01	8.00	2.00	8.00	0.00	6.00	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.71	34.51	12.07	4.67	4.56	2.73	2.96	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.00	12.23	3.85	2.75	2.75	4.12	1.24	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.39	5.25	3.73	2.54	2.54	1.69	1.19	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.15	7.51	2.43	1.85	3.00	1.39	2.43	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	11.46	7.35	2.35	5.00	2.65	1.76	2.65	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	54.19	8.41	5.61	2.80	3.74	3.74	5.61	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	20.36	9.12	5.51	1.48	2.97	2.33	2.12	1.06
ovary, adult, pool1	10020-101D2	22.19	4.63	2.53	7.16	2.45	2.27	1.83	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.65	9.53	2.20	2.20	1.47	2.02	0.37	1.10
pancreas, adult, donor1	10049-101G4	42.33	5.64	3.76	9.41	1.88	8.47	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.13	50.60	19.29	13.98	7.83	5.87	5.87	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	15.67	12.44	5.45	4.60	2.21	1.53	1.70	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.21	17.88	8.78	2.98	2.48	6.62	1.49	2.98
paracentral gyrus, adult, pool1	10035-101E8	18.76	4.03	1.01	9.06	0.82	0.82	1.56	0.18
parietal cortex, adult, donor10258	10373-105G4	11.74	3.67	2.20	5.14	2.94	5.14	2.20	0.73
parietal lobe - adult, donor10196	10171-103B9	13.17	3.76	3.76	4.70	0.00	2.82	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	21.66	5.13	1.71	6.27	0.57	1.43	1.71	0.29
parietal lobe, adult, pool1	10034-101E7	22.38	4.49	0.70	9.16	0.88	0.97	1.32	0.26
parietal lobe, fetal, donor1	10072-101I9	24.25	6.79	0.97	6.79	1.94	1.94	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.22	7.10	1.50	2.99	1.12	3.74	1.12	2.99
parotid gland, adult	10199-103F1	24.67	9.25	0.00	4.32	2.47	2.47	3.70	1.23
penis, adult	10200-103F2	19.34	10.74	1.07	4.30	2.15	1.07	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.94	3.16	1.49	6.32	2.79	2.42	1.30	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.72	16.17	5.10	3.35	3.21	1.31	1.89	1.17
pineal gland - adult, donor10196	10179-103C8	36.12	4.52	1.29	3.87	1.94	3.23	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	36.12	10.07	1.18	4.15	1.18	2.96	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	22.57	8.15	1.25	3.76	3.76	1.25	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	5.06	5.06	10.12	3.04	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	39.09	16.16	5.21	10.42	5.73	3.65	3.13	1.56
pituitary gland, adult, donor10258	10378-105G9	23.83	10.21	0.85	3.40	4.26	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	12.90	19.03	6.56	14.51	7.10	3.44	3.55	3.55
plasma cell leukemia cell line:ARH-77	10840-111E3	25.43	28.87	4.90	2.78	2.52	3.18	2.12	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	10.27	5.29	2.80	2.49	1.40	2.33	1.09	0.93
pons, adult, pool1	10033-101E6	14.89	4.30	1.29	5.59	1.03	1.29	0.86	0.09
postcentral gyrus, adult, pool1	10032-101E5	20.22	4.18	0.96	9.41	1.05	0.87	1.92	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	81.56	56.47	58.56	2.09	73.20	2.09	6.27	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	11.02	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	13.26	9.61	1.17	2.91	0.73	0.29	0.73	0.00
prostate cancer cell line:PC-3	10439-106E7	45.01	21.96	5.81	5.45	3.27	3.81	3.45	1.09
prostate, adult, pool1	10022-101D4	14.51	6.08	2.00	4.08	2.45	1.36	0.91	0.63
putamen, adult, donor10196	10176-103C5	20.07	8.73	1.89	13.69	1.18	3.07	3.78	0.71
putamen, adult, donor10252	10152-102I8	23.53	1.96	0.00	7.84	1.96	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	5.46	1.09	9.84	0.00	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.29	2.66	0.48	10.15	0.00	0.00	2.17	0.24
putamen, newborn, donor10223	10365-105F5	9.75	0.75	1.50	1.50	1.50	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.06	18.62	12.80	6.11	5.24	11.06	4.65	2.62
rectum, fetal, donor1	10067-101I4	20.86	43.12	2.78	5.56	1.39	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.02	9.12	3.82	2.97	0.21	0.42	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.31	3.31	0.00	1.66	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	29.12	12.92	5.37	8.95	2.88	3.18	2.48	1.09
retinoblastoma cell line:Y79	10475-106I7	47.54	16.63	3.90	1.82	2.60	3.12	2.60	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	32.21	16.23	3.07	3.81	1.35	2.83	2.21	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	140.04	82.67	12.09	19.40	2.81	29.81	12.65	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	22.74	8.34	0.76	0.00	0.76	1.52	3.03	0.00
salivary acinar cells, donor1	11771-123I7	11.98	12.46	1.94	2.91	0.81	0.81	1.46	0.00
salivary acinar cells, donor2	11772-123I8	9.91	11.43	2.07	4.41	1.51	0.96	1.79	0.55
salivary acinar cells, donor3	11773-123I9	13.24	19.86	2.65	3.31	3.31	1.99	1.99	0.00
salivary gland, adult, pool1	10093-102C3	21.16	6.86	3.43	7.44	2.29	1.14	2.29	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.69	16.78	2.87	1.18	1.43	1.10	0.76	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.85	14.11	2.82	1.65	1.76	0.71	1.88	0.24
seminal vesicle, adult	10201-103F3	34.92	12.70	1.06	3.70	5.29	1.59	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.04	17.25	7.04	7.53	3.16	3.40	2.43	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.85	4.53	3.52	3.52	2.01	1.51	1.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	10.04	9.03	5.02	3.01	1.00	4.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	7.25	10.07	5.91	3.90	1.61	1.21	1.07	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	12.49	20.01	4.64	1.33	2.32	1.11	1.11	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.22	11.87	3.35	2.32	1.55	3.35	1.55	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	4.97	0.71	0.71	0.71	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	25.79	6.12	1.44	3.36	0.72	1.68	1.32	0.12
skeletal muscle, fetal, donor1	10066-101I3	18.09	16.08	4.02	4.02	7.04	1.01	1.01	1.01
skin, adult, donor1	10074-102A2	54.28	27.14	0.00	27.14	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	10.10	3.79	10.10	0.00	4.42	4.42	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.01	22.35	5.00	3.67	2.33	1.67	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.35	15.45	5.99	4.10	4.73	1.89	1.89	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	8.87	21.01	5.40	15.61	3.28	0.58	1.35	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	30.66	8.08	4.45	3.79	2.31	1.98	2.97	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	57.10	9.17	3.06	18.66	2.57	3.86	2.25	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	12.20	20.92	4.58	1.31	1.74	0.22	1.09	0.87
small intestine, adult, pool1	10024-101D6	31.65	17.68	3.46	11.35	3.58	5.73	5.26	0.96
small intestine, fetal, donor1	10064-101I1	18.67	19.41	2.21	4.18	2.46	4.42	1.97	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.21	7.18	4.10	2.05	7.69	1.03	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	20.42	4.65	1.55	1.03	2.33	1.29	1.03	0.52
somatostatinoma cell line:QGP-1	10781-110G7	10.72	23.32	6.70	9.11	8.31	1.61	4.82	1.61
spinal cord - adult, donor10196	10181-103D1	21.79	14.68	2.98	13.08	2.52	2.98	2.29	0.23
spinal cord, adult, donor10252	10159-103A6	24.44	9.07	2.37	9.46	2.37	2.76	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	4.15	1.38	0.69	6.92	2.08	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	20.73	10.37	3.05	8.54	1.83	3.05	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	13.32	3.21	5.51	4.59	1.38	1.38	3.21	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.09	10.90	0.90	3.58	1.05	1.79	1.94	0.60
spleen, adult, pool1	10025-101D7	29.41	20.48	5.29	6.28	6.50	4.41	2.64	1.21
spleen, fetal, pool1	10044-101F8	27.89	18.75	9.53	7.23	8.82	2.70	4.21	3.02
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	27.74	14.49	4.35	2.59	2.48	3.00	1.66	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.34	10.82	4.75	2.66	4.37	1.33	1.33	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.13	17.12	3.84	4.19	1.40	0.35	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.87	18.76	9.77	0.78	3.91	4.69	0.78	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.73	4.28	3.94	1.58	2.81	1.58	0.45	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	52.95	11.86	6.35	5.51	3.81	2.12	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.54	34.69	3.38	2.54	1.69	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	37.38	14.95	3.20	1.07	3.20	1.07	4.27	1.07
submaxillary gland, adult	10202-103F4	22.22	6.84	1.71	6.84	2.85	2.28	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	23.06	5.19	2.70	4.57	2.28	2.08	0.42	1.04
substantia nigra, adult, donor10258	10371-105G2	8.28	1.55	0.52	5.17	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	12.72	7.07	1.41	7.07	2.12	5.65	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.08	24.99	6.88	15.82	3.44	7.11	5.04	0.46
temporal lobe, adult, pool1	10031-101E4	21.19	4.41	0.85	9.24	0.93	1.19	1.36	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.20	7.12	0.71	7.83	2.85	1.42	4.99	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	21.54	3.08	2.20	8.79	2.20	0.88	2.64	0.88
tenocyte, donor1	11763-123H8	15.36	4.89	1.75	2.44	1.75	1.40	1.05	0.35
tenocyte, donor2	11765-123I1	9.92	4.20	1.14	3.05	0.76	0.38	2.29	0.38
tenocyte, donor3	11768-123I4	13.71	2.59	0.37	2.97	0.37	2.22	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.25	24.64	8.50	5.44	5.27	9.86	4.25	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	19.42	14.03	6.32	6.32	2.47	4.47	4.16	0.92
teratocarcinoma cell line:PA-1	10807-111A6	59.20	15.34	4.96	10.07	3.41	8.37	6.97	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.82	20.95	17.26	5.97	9.27	4.57	3.94	5.20
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	21.18	21.18	12.48	5.29	6.05	1.89	2.27	5.67
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.31	16.80	24.76	10.80	10.14	6.00	6.22	7.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.33	14.01	17.26	10.10	9.12	9.45	5.21	4.23
testis, adult, pool1	10026-101D8	32.75	28.13	7.73	14.07	4.08	5.05	4.08	1.61
testis, adult, pool2	10096-102C6	58.19	59.09	22.55	25.71	7.22	9.92	4.96	4.96
thalamus - adult, donor10196	10168-103B6	23.18	1.10	1.10	8.83	0.00	3.31	1.10	1.10
thalamus, adult, donor10252	10154-103A1	21.41	6.56	2.66	7.50	1.72	2.19	1.25	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	4.62	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.26	3.46	0.66	3.62	0.66	1.32	0.33	0.49
thalamus, newborn, donor10223	10366-105F6	6.90	2.30	1.15	0.00	0.58	1.15	0.00	1.73
throat, adult	10209-103G2	20.47	8.99	3.25	3.00	2.25	1.00	1.00	0.50
throat, fetal, donor1	10061-101H7	18.59	12.80	4.57	5.48	3.05	2.13	1.52	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	40.74	23.45	7.15	8.55	3.58	3.97	5.76	0.60
thymus, adult, pool1	10027-101D9	14.71	18.59	15.91	11.43	21.87	2.78	9.54	7.95
thymus, fetal, pool1	10043-101F7	15.90	24.11	16.83	7.90	25.46	4.36	6.03	12.68
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.40	13.83	3.99	3.46	4.92	3.46	1.20	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	28.36	21.51	3.49	5.73	4.19	3.77	2.79	0.98
thyroid, adult, pool1	10028-101E1	19.78	12.41	5.23	2.99	4.01	1.77	1.31	0.65
thyroid, fetal, donor1	10060-101H6	23.73	25.84	5.54	4.22	3.16	1.58	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	6.16	6.16	6.16	6.16	3.08	6.16	0.00
tongue, adult	10203-103F5	15.35	11.16	2.79	3.49	2.09	1.40	1.86	0.70
tongue, fetal, donor1	10059-101H5	15.37	7.49	2.76	3.94	1.97	0.79	0.79	0.39
tonsil, adult, pool1	10047-101G2	31.96	19.03	9.02	7.71	8.51	3.41	3.31	2.00
trachea, adult, pool1	10029-101E2	17.67	10.22	5.40	5.40	4.25	2.21	2.29	0.90
trachea, fetal, donor1	10058-101H4	18.47	11.54	3.08	5.39	3.08	2.31	1.54	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	25.86	10.27	2.13	2.83	1.42	2.83	2.83	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	26.65	20.47	4.36	3.75	3.65	2.63	1.93	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.02	21.00	5.17	3.29	2.04	1.57	3.45	0.31
tridermal teratoma cell line:HGRT	10694-109G1	22.83	15.22	1.90	1.90	5.71	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.72	8.72	2.71	2.54	2.20	1.35	2.20	0.85
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	6.26	2.09	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	29.52	7.17	2.73	6.48	4.27	1.54	1.71	1.54
uterus, fetal, donor1	10055-101H1	21.50	10.24	3.58	4.10	3.58	3.07	2.56	0.51
vagina, adult	10204-103F6	23.91	10.34	2.58	5.82	2.58	9.05	0.65	2.58
vein, adult	10191-103E2	21.48	11.18	3.29	2.41	5.04	2.19	2.19	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.62	11.48	3.20	0.27	1.34	0.80	1.07	0.00